
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="68F7DE7A80950C2300DE7A003999BAF7.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955787/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Basic &amp; Clinical Pharmacology &amp; Toxicology">
<meta name="citation_title" content="Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction">
<meta name="citation_author" content="Ana M Briones">
<meta name="citation_author_institution" content="Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain">
<meta name="citation_author_institution" content="Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain">
<meta name="citation_author_institution" content="CIBER Cardiovascular (CIBERCV), Madrid, Spain">
<meta name="citation_author" content="Raquel Hernanz">
<meta name="citation_author_institution" content="Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain">
<meta name="citation_author_institution" content="CIBER Cardiovascular (CIBERCV), Madrid, Spain">
<meta name="citation_author_institution" content="Department of Basic Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain">
<meta name="citation_author" content="Ana B García‐Redondo">
<meta name="citation_author_institution" content="Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain">
<meta name="citation_author_institution" content="CIBER Cardiovascular (CIBERCV), Madrid, Spain">
<meta name="citation_author_institution" content="Department of Physiology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain">
<meta name="citation_author" content="Cristina Rodríguez">
<meta name="citation_author_institution" content="CIBER Cardiovascular (CIBERCV), Madrid, Spain">
<meta name="citation_author_institution" content="Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain">
<meta name="citation_author" content="Luis M Blanco‐Colio">
<meta name="citation_author_institution" content="CIBER Cardiovascular (CIBERCV), Madrid, Spain">
<meta name="citation_author_institution" content="Laboratory for Vascular Biology, IIS‐Fundación Jiménez Díaz, Madrid, Spain">
<meta name="citation_author" content="Almudena Val‐Blasco">
<meta name="citation_author_institution" content="Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain">
<meta name="citation_author_institution" content="CIBER Cardiovascular (CIBERCV), Madrid, Spain">
<meta name="citation_author" content="María J Alonso">
<meta name="citation_author_institution" content="Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain">
<meta name="citation_author_institution" content="CIBER Cardiovascular (CIBERCV), Madrid, Spain">
<meta name="citation_author_institution" content="Department of Basic Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain">
<meta name="citation_author" content="Mercedes Salaices">
<meta name="citation_author_institution" content="Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain">
<meta name="citation_author_institution" content="Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain">
<meta name="citation_author_institution" content="CIBER Cardiovascular (CIBERCV), Madrid, Spain">
<meta name="citation_publication_date" content="2025 Mar 31">
<meta name="citation_volume" content="136">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70026">
<meta name="citation_doi" content="10.1111/bcpt.70026">
<meta name="citation_pmid" content="40159875">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955787/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955787/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955787/pdf/BCPT-136-0.pdf">
<meta name="description" content="Excessive local inflammation is a common mechanism in many cardiovascular diseases (CVDs) such as hypertension, atherosclerosis and aortic aneurysms. In endothelial cells, inflammatory cytokines such as interferons, tumour necrosis factor alpha or ...">
<meta name="og:title" content="Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Excessive local inflammation is a common mechanism in many cardiovascular diseases (CVDs) such as hypertension, atherosclerosis and aortic aneurysms. In endothelial cells, inflammatory cytokines such as interferons, tumour necrosis factor alpha or ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955787/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11955787">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/bcpt.70026"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/BCPT-136-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11955787%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11955787/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11955787/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955787/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/bcpt.70026" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Basic Clin Pharmacol Toxicol</button></div>. 2025 Mar 31;136(5):e70026. doi: <a href="https://doi.org/10.1111/bcpt.70026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/bcpt.70026</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Basic%20Clin%20Pharmacol%20Toxicol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Briones%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Ana M Briones</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Ana M Briones</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Briones%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ana M Briones</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hernanz%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Raquel Hernanz</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Raquel Hernanz</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Basic Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hernanz%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Raquel Hernanz</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Garc%C3%ADa%E2%80%90Redondo%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ana B García‐Redondo</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Ana B García‐Redondo</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div class="p">
<sup>
<sup>5</sup>
</sup>Department of Physiology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Garc%C3%ADa%E2%80%90Redondo%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ana B García‐Redondo</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodr%C3%ADguez%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Cristina Rodríguez</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Cristina Rodríguez</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div class="p">
<sup>
<sup>6</sup>
</sup>Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodr%C3%ADguez%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cristina Rodríguez</span></a>
</div>
</div>
<sup>3,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blanco%E2%80%90Colio%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Luis M Blanco‐Colio</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Luis M Blanco‐Colio</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div class="p">
<sup>
<sup>7</sup>
</sup>Laboratory for Vascular Biology, IIS‐Fundación Jiménez Díaz, Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blanco%E2%80%90Colio%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Luis M Blanco‐Colio</span></a>
</div>
</div>
<sup>3,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Val%E2%80%90Blasco%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Almudena Val‐Blasco</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Almudena Val‐Blasco</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Val%E2%80%90Blasco%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Almudena Val‐Blasco</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alonso%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">María J Alonso</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">María J Alonso</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Basic Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alonso%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">María J Alonso</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salaices%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Mercedes Salaices</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Mercedes Salaices</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salaices%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mercedes Salaices</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="bcpt70026-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain</div>
<div id="bcpt70026-aff-0002">
<sup>
<sup>2</sup>
</sup>Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain</div>
<div id="bcpt70026-aff-0003">
<sup>
<sup>3</sup>
</sup>CIBER Cardiovascular (CIBERCV), Madrid, Spain</div>
<div id="bcpt70026-aff-0004">
<sup>
<sup>4</sup>
</sup>Department of Basic Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain</div>
<div id="bcpt70026-aff-0005">
<sup>
<sup>5</sup>
</sup>Department of Physiology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain</div>
<div id="bcpt70026-aff-0006">
<sup>
<sup>6</sup>
</sup>Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain</div>
<div id="bcpt70026-aff-0007">
<sup>
<sup>7</sup>
</sup>Laboratory for Vascular Biology, IIS‐Fundación Jiménez Díaz, Madrid, Spain</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Ana M. Briones (<span>ana.briones@uam.es</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Feb 20; Received 2024 Nov 24; Accepted 2025 Mar 10; Issue date 2025 May.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Basic &amp; Clinical Pharmacology &amp; Toxicology</em> published by John Wiley &amp; Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11955787  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40159875/" class="usa-link">40159875</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Excessive local inflammation is a common mechanism in many cardiovascular diseases (CVDs) such as hypertension, atherosclerosis and aortic aneurysms. In endothelial cells, inflammatory cytokines such as interferons, tumour necrosis factor alpha or interleukins increase oxidative stress and contractile prostanoids and the expression of adhesion molecules that reduce nitric oxide (NO) availability and bind leucocytes, thereby impairing endothelial function. Despite this evidence, anti‐inflammatory therapies are not yet indicated for the treatment of most CVD. Resolution of inflammation is mediated by a family of specialized pro‐resolving mediators (SPMs) that act on cognate G protein–coupled receptors to limit immune cell infiltration and initiate tissue repair. SPMs, generated from omega‐3 and omega‐6 polyunsaturated fatty acids, belong to four major families: lipoxins, resolvins, protectins and maresins. SPM receptors are expressed in immune and vascular cells where they regulate important processes such as phagocytosis and polarization, production of cytokines, NO and prostacyclin, and modulation of smooth muscle cell phenotype. Growing evidence in animal models demonstrates that activation of SPM receptors can protect vascular function and structure and provide beneficial effects in various CVD. We will review recent advances in the role of inflammation and SPMs in vascular (dys)function in hypertension, atherosclerosis, and aortic aneurysms.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> cardiovascular diseases, endothelial dysfunction, hypertension, inflammation, specialized proresolvin mediators</p></section></section><hr class="headless">
<section class="bt xbox font-sm" id="bcpt70026-blkfxd-0001"><h2 class="obj_head">Summary.</h2>
<ul id="bcpt70026-list-0001" class="list" style="list-style-type:disc">
<li id="bcpt70026-li-0001"><p>Excessive inflammation in the arteries is a common feature of many cardiovascular diseases such as hypertension, atherosclerosis, and aortic aneurysms.</p></li>
<li id="bcpt70026-li-0002"><p>Many inflammatory factors damage the vasculature by reducing the availability of key vasodilator factors and facilitating the recruitment of immune cells that further perpetuate the damage.</p></li>
<li id="bcpt70026-li-0003"><p>Despite this evidence, anti‐inflammatory therapies are not yet indicated for the treatment of most cardiovascular diseases.</p></li>
<li id="bcpt70026-li-0004"><p>Specialized pro‐resolving mediators are molecules that act on vascular and immune cells to regulate important processes involved in the proper functioning of the vasculature and can provide beneficial effects in several cardiovascular diseases.</p></li>
</ul></section><section id="bcpt70026-sec-0002"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>The vascular endothelium is a semipermeable barrier involved in critical physiological functions such as exchange of substances and fluids, control of vascular tone, mechanotransduction, haemostasia, angiogenesis, injury and repair and metabolism [<a href="#bcpt70026-bib-0001" class="usa-link" aria-describedby="bcpt70026-bib-0001">1</a>, <a href="#bcpt70026-bib-0002" class="usa-link" aria-describedby="bcpt70026-bib-0002">2</a>, <a href="#bcpt70026-bib-0003" class="usa-link" aria-describedby="bcpt70026-bib-0003">3</a>]. Endothelial cell (EC) function can be influenced by proximal cells such as immune cells, fibroblasts or cardiomyocytes, and similarly, EC can affect the behaviour of such cells. In response to various stressors including lipid products, inflammatory cytokines, changes in blood flow, oxidative stress, metabolic factors, some drugs or cardiovascular risk factors, the EC become dysfunctional and shift the production of protective molecules towards factors that promote major features of endothelial dysfunction that contribute to many cardiovascular diseases (CVDs) [<a href="#bcpt70026-bib-0001" class="usa-link" aria-describedby="bcpt70026-bib-0001">1</a>, <a href="#bcpt70026-bib-0002" class="usa-link" aria-describedby="bcpt70026-bib-0002">2</a>, <a href="#bcpt70026-bib-0003" class="usa-link" aria-describedby="bcpt70026-bib-0003">3</a>].</p>
<p>It is recognized that endothelial dysfunction is an initiating or contributing factor in many CVDs such as hypertension, atherosclerosis, diabetes, obesity or aortic aneurysms. This highlights the need to find therapeutic strategies to prevent or reverse endothelial dysfunction in order to maintain vascular health. In this context, many, if not all, CVDs associated with endothelial dysfunction are now considered low‐grade inflammatory diseases with increased production of vascular inflammatory mediators locally or from infiltrated or circulating immune cells that negatively affect ECs [<a href="#bcpt70026-bib-0004" class="usa-link" aria-describedby="bcpt70026-bib-0004">4</a>, <a href="#bcpt70026-bib-0005" class="usa-link" aria-describedby="bcpt70026-bib-0005">5</a>].</p>
<p>In this review, we will provide an overview of the role of inflammation in different features of endothelial dysfunction in hypertension and other CVDs. We also propose additional approaches to resolve the inflammatory response in EC as novel pharmacological tools to treat endothelial dysfunction with potential impact in various CVDs.</p></section><section id="bcpt70026-sec-0003"><h2 class="pmc_sec_title">2. Endothelial Dysfunction and Inflammation</h2>
<p>Endothelial dysfunction is characterized by several features including inflammation, hyperpermeability, leukocyte adhesion, endothelial NO synthase (eNOS) uncoupling, altered EC metabolism, oxidative stress, injury and cell death, senescence, endothelial–mesenchymal transition and impaired vasodilation [<a href="#bcpt70026-bib-0001" class="usa-link" aria-describedby="bcpt70026-bib-0001">1</a>, <a href="#bcpt70026-bib-0002" class="usa-link" aria-describedby="bcpt70026-bib-0002">2</a>, <a href="#bcpt70026-bib-0003" class="usa-link" aria-describedby="bcpt70026-bib-0003">3</a>]. Chronic exposure to cardiovascular risk factors such as hypertension, hypercholesterolaemia, diabetes or obesity reduces endothelium‐dependent relaxation, and this has a prognostic value for future cardiovascular events [<a href="#bcpt70026-bib-0006" class="usa-link" aria-describedby="bcpt70026-bib-0006">6</a>]. Therefore, targeting factors that impair vascular relaxation would have a major impact on cardiovascular morbidity and mortality. In healthy conditions, the endothelium releases NO, prostacyclin, and endothelium‐derived hyperpolarizing factors (EDHF) such as hydrogen sulfide (H<sub>2</sub>S), carbon monoxide, arachidonic acid metabolites, and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), which, at physiological concentrations, are key factors in the regulation of the vascular tone. However, in cardiovascular comorbidities such as hypertension, the endothelium also releases vasoconstrictor molecules such as endothelin‐1 (ET‐1), angiotensin II (Ang II), thromboxane A<sub>2</sub>, or superoxide anion, which contribute to the impaired vasodilator responses observed in these diseases [<a href="#bcpt70026-bib-0001" class="usa-link" aria-describedby="bcpt70026-bib-0001">1</a>, <a href="#bcpt70026-bib-0002" class="usa-link" aria-describedby="bcpt70026-bib-0002">2</a>, <a href="#bcpt70026-bib-0003" class="usa-link" aria-describedby="bcpt70026-bib-0003">3</a>]. Moreover, multiple risk factors including EC injury, lipids, peptides such as Ang II or ET‐1, metabolic factors, and hormones such as aldosterone trigger the expression of cytokines, monocyte chemoattractant protein‐1 (MCP‐1), chemokines and cell adhesion molecules (vascular cell adhesion molecule‐1 [VCAM‐1], intercellular cell adhesion molecule‐1 [ICAM‐1] and selectins) by EC, which increase permeability and attract inflammatory immune cells into the sub‐endothelial space, initiating local and systemic inflammation [<a href="#bcpt70026-bib-0004" class="usa-link" aria-describedby="bcpt70026-bib-0004">4</a>, <a href="#bcpt70026-bib-0005" class="usa-link" aria-describedby="bcpt70026-bib-0005">5</a>, <a href="#bcpt70026-bib-0007" class="usa-link" aria-describedby="bcpt70026-bib-0007">7</a>].</p>
<p>In the first part of the review, we will focus on the effect of different proinflammatory cytokines as mediators of impaired endothelial function in hypertension through the production of contractile factors such as reactive oxygen species (ROS) and prostanoids.</p>
<section id="bcpt70026-sec-0004"><h3 class="pmc_sec_title">2.1. Inflammatory Cytokines and Endothelial Dysfunction in Hypertension</h3>
<p>It is recognized that low‐grade immune response plays an important role in the initiation and maintenance of high blood pressure [<a href="#bcpt70026-bib-0004" class="usa-link" aria-describedby="bcpt70026-bib-0004">4</a>]. In hypertension, blood vessels are exposed to several insults that promote the release of the so‐called damage‐associated molecular patterns (DAMPs), which are recognized by pattern recognition receptors (PPRs); upon PPR activation, proinflammatory cytokines are produced by immune and vascular cells, and EC adopt a proinflammatory and prothrombotic phenotype, characterized by decreased release of vasodilator factors and increased release of vasoconstrictor factors, thereby reducing vasodilatory capacity [<a href="#bcpt70026-bib-0004" class="usa-link" aria-describedby="bcpt70026-bib-0004">4</a>]. Toll‐like receptors (TLRs) are a well‐characterized family of membrane‐bound PRRs expressed in various cell types, including vascular cells. Several studies have demonstrated upregulation of TLR4 in various models of hypertension, contributing to hypertension‐associated endothelial dysfunction through ROS‐dependent mechanisms [<a href="#bcpt70026-bib-0008" class="usa-link" aria-describedby="bcpt70026-bib-0008">8</a>, <a href="#bcpt70026-bib-0009" class="usa-link" aria-describedby="bcpt70026-bib-0009">9</a>].</p>
<p>Cytokines are mediators that coordinate innate and adaptive immune responses. They are produced by immune cells but also by EC, vascular smooth muscle cells (VSMC) and perivascular adipose tissue (PVAT). Cytokines have a major impact on the structure and function of blood vessels in hypertension. Alterations in the balance between pro‐ and anti‐inflammatory cytokines can drive the host defence immune response towards either chronic inflammation or resolution and healing. In both patients and animal models of hypertension, levels of several proinflammatory cytokines are increased, whereas those of anti‐inflammatory cytokines are decreased, and this is associated with end‐organ damage, including altered blood vessels function [<a href="#bcpt70026-bib-0004" class="usa-link" aria-describedby="bcpt70026-bib-0004">4</a>, <a href="#bcpt70026-bib-0010" class="usa-link" aria-describedby="bcpt70026-bib-0010">10</a>].</p>
<p>Tumour necrosis factor‐α (TNFα) is produced by T lymphocytes, VSMC, EC, adipocytes, macrophages and fibroblasts. After interacting with its receptors, NADPH oxidase is activated, mainly producing superoxide anion, which reacts with NO to form peroxynitrite (ONOO−) [<a href="#bcpt70026-bib-0011" class="usa-link" aria-describedby="bcpt70026-bib-0011">11</a>]; this reduces NO bioavailability, impairing vasodilation and increasing blood pressure. In addition, TNF‐α negatively regulates the eNOS promoter and contributes to the destabilization of the eNOS mRNA structure, leading to the massive degradation of eNOS with a reduction in NO synthesis [<a href="#bcpt70026-bib-0012" class="usa-link" aria-describedby="bcpt70026-bib-0012">12</a>]. Furthermore, TNF‐α increases ICAM‐1 and VCAM‐1 expression by activating the NF‐κB pathway, facilitating immune cell recruitment and vascular dysfunction [<a href="#bcpt70026-bib-0013" class="usa-link" aria-describedby="bcpt70026-bib-0013">13</a>].</p>
<p>Interleukin‐6 (IL‐6), secreted by circulating leucocytes, EC, VSCM and fibroblasts, also induces endothelial dysfunction and contributes to the development of hypertension. IL‐6 is thought to reduce eNOS activation by increasing the half‐life of caveolin‐1 and, consequently reducing Ser<sup>1177</sup> phosphorylation (the eNOS stimulatory site) [<a href="#bcpt70026-bib-0014" class="usa-link" aria-describedby="bcpt70026-bib-0014">14</a>]. Additionally, experiments performed in Ang II‐infused IL‐6‐deficient mice have shown that this cytokine also induces oxidative stress and reduces eNOS expression [<a href="#bcpt70026-bib-0015" class="usa-link" aria-describedby="bcpt70026-bib-0015">15</a>], thereby limiting NO bioavailability and vasodilation.</p>
<p>IL‐1β is primarily derived from monocytes, T cells and neutrophils. It is released into the extracellular space after pro‐IL‐1β processing by inflammatory caspases. Its receptors are expressed on immune cells, VSMCs and ECs. IL‐1β activates NADPH oxidase and ROS production and induces the expression of the inducible cyclooxygenase 2 (COX‐2) [<a href="#bcpt70026-bib-0016" class="usa-link" aria-describedby="bcpt70026-bib-0016">16</a>, <a href="#bcpt70026-bib-0017" class="usa-link" aria-describedby="bcpt70026-bib-0017">17</a>]. Various approaches targeting IL‐1β prevented aldosterone‐induced endothelial dysfunction [<a href="#bcpt70026-bib-0018" class="usa-link" aria-describedby="bcpt70026-bib-0018">18</a>]. Moreover, anakinra, an IL‐1R1 receptor inhibitor, prevents endothelial dysfunction induced by macrophage‐conditioned media from Ang II‐induced hypertensive mice [<a href="#bcpt70026-bib-0019" class="usa-link" aria-describedby="bcpt70026-bib-0019">19</a>].</p>
<p>Activation of the mineralocorticoid receptor in CD8+T cells induces hypertension and endothelial dysfunction via Interferon‐γ (IFN‐γ) [<a href="#bcpt70026-bib-0020" class="usa-link" aria-describedby="bcpt70026-bib-0020">20</a>]. IFN‐γ is mainly produced by T helper I cells, effector CD8<sup>+</sup> T cells and natural killer (NK) cells. Its receptor is expressed on most cells, and, when activated, it induces oxidative stress and inflammation, endothelial dysfunction, vascular remodelling and fibrosis in hypertension [<a href="#bcpt70026-bib-0021" class="usa-link" aria-describedby="bcpt70026-bib-0021">21</a>]. Moreover, IFN‐γ stimulates interferon‐stimulated genes, such as ISG15, which contribute to endothelial dysfunction and vascular remodelling in hypertension through inflammatory mechanisms and oxidative stress [<a href="#bcpt70026-bib-0022" class="usa-link" aria-describedby="bcpt70026-bib-0022">22</a>].</p>
<p>The proinflammatory cytokine IL‐17A is derived from Th17 cells, an important subset of CD4<sup>+</sup> T cells. In EC, IL‐17A inhibits eNOS by inducing Thr<sup>495</sup> phosphorylation (the eNOS inhibitory site) and reducing Ser<sup>1177</sup> phosphorylation, resulting in decreased NO production [<a href="#bcpt70026-bib-0023" class="usa-link" aria-describedby="bcpt70026-bib-0023">23</a>]. Moreover, Ang II infusion failed to induce endothelial dysfunction or to increase blood pressure in 17A<sup>−/−</sup> mice, and this was associated with a reduced superoxide production and decreased T‐cell infiltration [<a href="#bcpt70026-bib-0024" class="usa-link" aria-describedby="bcpt70026-bib-0024">24</a>].</p>
<p>IL‐22, a member of the IL‐10 cytokine family, is mainly produced by CD4<sup>+</sup> Th1, Th17 and Th22 cells, as well as NK and γδ T cells. Binding to specific cell surface receptors induces JAK/STAT3 signalling and subsequent eNOS phosphorylation at Thr<sup>495</sup>, which contributes to impaired NO‐dependent relaxation in Ang II‐infused mice [<a href="#bcpt70026-bib-0025" class="usa-link" aria-describedby="bcpt70026-bib-0025">25</a>].</p>
<p>IL‐10 is an anti‐inflammatory cytokine with protective effects in hypertension and endothelial dysfunction. It is secreted by regulatory T cells (Tregs), monocytes, macrophages, dendritic cells, NK cells, and B cells and limits the host immune response. Through its receptor, IL‐10 activates the JAK/STAT pathway and reduces the release of proinflammatory cytokines such as IFN‐γ, IL‐1β, TNF‐α, and IL‐6. Several reports have shown that IL‐10 protects against Ang II‐induced impaired vasodilation by suppressing oxidative stress [<a href="#bcpt70026-bib-0026" class="usa-link" aria-describedby="bcpt70026-bib-0026">26</a>, <a href="#bcpt70026-bib-0027" class="usa-link" aria-describedby="bcpt70026-bib-0027">27</a>].</p>
<p>Taken together, these findings indicate that proinflammatory cytokines induce endothelial dysfunction in hypertension mainly by reducing eNOS activation and through oxidative stress–dependent mechanisms.</p></section><section id="bcpt70026-sec-0005"><h3 class="pmc_sec_title">2.2. ROS and Endothelial Dysfunction in Hypertension</h3>
<p>High plasma and vascular levels of ROS have been extensively described in both animal models and hypertensive patients [<a href="#bcpt70026-bib-0028" class="usa-link" aria-describedby="bcpt70026-bib-0028">28</a>, <a href="#bcpt70026-bib-0029" class="usa-link" aria-describedby="bcpt70026-bib-0029">29</a>, <a href="#bcpt70026-bib-0030" class="usa-link" aria-describedby="bcpt70026-bib-0030">30</a>, <a href="#bcpt70026-bib-0031" class="usa-link" aria-describedby="bcpt70026-bib-0031">31</a>]. When produced at pathological levels by various cell types, ROS reduce NO bioavailability and function and are important second messengers in EC signalling. Indeed, an imbalance between antioxidant defence mechanisms and ROS production is considered a primary cause of endothelial dysfunction. A dysfunctional endothelium also exacerbates the production of ROS, which can activate redox‐sensitive transcription factors (e.g., NF‐κB and AP‐1) involved in the expression of proinflammatory genes and cytokines that further perpetuate vascular inflammation and endothelial damage [<a href="#bcpt70026-bib-0030" class="usa-link" aria-describedby="bcpt70026-bib-0030">30</a>, <a href="#bcpt70026-bib-0031" class="usa-link" aria-describedby="bcpt70026-bib-0031">31</a>].</p>
<p>The major source of ROS in hypertension is the NADPH oxidase family, whose expression and activity are increased at the vascular level. The NADPH oxidase isoforms Nox‐1, Nox‐2, Nox‐4 and Nox‐5, the latter of which is only expressed in humans, are expressed in fibroblasts, EC and VSMC and are regulated by growth factors, elevated intravascular pressure, proinflammatory mediators and vasoactive agents such as ET‐1 and Ang II [<a href="#bcpt70026-bib-0030" class="usa-link" aria-describedby="bcpt70026-bib-0030">30</a>, <a href="#bcpt70026-bib-0031" class="usa-link" aria-describedby="bcpt70026-bib-0031">31</a>]. Nox signalling involves activation of multiple pathways, including endoplasmic reticulum stress, NF‐κB or various kinases, resulting in oxidative stress, inflammation, endothelial damage and high blood pressure [<a href="#bcpt70026-bib-0030" class="usa-link" aria-describedby="bcpt70026-bib-0030">30</a>, <a href="#bcpt70026-bib-0031" class="usa-link" aria-describedby="bcpt70026-bib-0031">31</a>]. Other important sources of ROS in hypertension are mitochondria, xanthine oxidase and uncoupled eNOS. In hypertension, certain points in the electron transport chain can ‘leak’ electrons to oxygen, resulting in the formation of superoxide, which is rapidly converted to H<sub>2</sub>O<sub>2</sub> by the enzyme superoxide dismutase 2 (SOD2). H<sub>2</sub>O<sub>2</sub> can easily diffuse out of the mitochondria, contributing to cellular oxidative stress [<a href="#bcpt70026-bib-0032" class="usa-link" aria-describedby="bcpt70026-bib-0032">32</a>]. It has been observed that NADPH oxidase‐derived ROS stimulates mitochondria ROS and vice versa, creating a vicious feed‐forward cycle implicated in endothelial dysfunction and elevated blood pressure in hypertension [<a href="#bcpt70026-bib-0029" class="usa-link" aria-describedby="bcpt70026-bib-0029">29</a>, <a href="#bcpt70026-bib-0032" class="usa-link" aria-describedby="bcpt70026-bib-0032">32</a>].</p>
<p>Endothelial NOS can also generate ROS in the absence of L‐arginine substrate or tetrahydrobiopterin (BH4) cofactor. This phenomenon is referred to as eNOS uncoupling and has been demonstrated in several models of hypertension [<a href="#bcpt70026-bib-0030" class="usa-link" aria-describedby="bcpt70026-bib-0030">30</a>, <a href="#bcpt70026-bib-0033" class="usa-link" aria-describedby="bcpt70026-bib-0033">33</a>]. Several factors, including oxidative stress and Ang II, reduce the bioavailability of BH4 by downregulating dihydrofolate reductase, which is involved in the synthesis of this cofactor [<a href="#bcpt70026-bib-0034" class="usa-link" aria-describedby="bcpt70026-bib-0034">34</a>]. In addition, superoxide anion and ONOO− oxidase BH4 to dihydropterin (BH2), leading to uncoupled eNOS and superoxide anion production rather than NO. [<a href="#bcpt70026-bib-0033" class="usa-link" aria-describedby="bcpt70026-bib-0033">33</a>]</p>
<p>The bioavailability of ROS is tightly regulated by the balance between generation and detoxification by several antioxidant mechanisms, including enzymes such as glutathione peroxidase (GPx), SODs, catalase or the thioredoxin system and non‐enzymatic molecules, such as tocopherols or ascorbic acid [<a href="#bcpt70026-bib-0030" class="usa-link" aria-describedby="bcpt70026-bib-0030">30</a>]. Therefore, a disturbance in any of these mechanisms can lead to pathological levels of ROS. Reduced expression and activity of SOD, catalase and GPx have been described in hypertensive patients and models of hypertension [<a href="#bcpt70026-bib-0030" class="usa-link" aria-describedby="bcpt70026-bib-0030">30</a>, <a href="#bcpt70026-bib-0035" class="usa-link" aria-describedby="bcpt70026-bib-0035">35</a>, <a href="#bcpt70026-bib-0036" class="usa-link" aria-describedby="bcpt70026-bib-0036">36</a>]. Interestingly, activation of nuclear factor erythroid 2‐related factor‐2 (Nrf2), an oxidative stress‐responsive factor that activates transcription of genes encoding several antioxidant and detoxifying proteins, such as NAD(P)H quinone reductase 1, heme oxygenase 1, SOD1/2, GPx and catalase [<a href="#bcpt70026-bib-0037" class="usa-link" aria-describedby="bcpt70026-bib-0037">37</a>], prevents endothelial dysfunction, inflammation and hypertension in several animal models [<a href="#bcpt70026-bib-0036" class="usa-link" aria-describedby="bcpt70026-bib-0036">36</a>, <a href="#bcpt70026-bib-0037" class="usa-link" aria-describedby="bcpt70026-bib-0037">37</a>]. In addition, several studies have shown that various antioxidants and inhibitors of ROS production improve endothelial function in different models of hypertension. Similarly, genetic deletion of different NADPH oxidase isoforms or other sources of ROS preserve vascular function in response to hypertensive challenge. However, data from clinical trials with antioxidants have yielded mixed results, which may be due to different biological factors, inadequate or incomplete ROS measurement, chemical reactivity problems or pathophysiological or pharmacokinetic aspects. We will not discuss this aspect in detail, and the reader is referred to previous reviews [ <a href="#bcpt70026-bib-0030" class="usa-link" aria-describedby="bcpt70026-bib-0030">30</a>, <a href="#bcpt70026-bib-0031" class="usa-link" aria-describedby="bcpt70026-bib-0031">31</a>, <a href="#bcpt70026-bib-0038" class="usa-link" aria-describedby="bcpt70026-bib-0038">38</a>].</p></section><section id="bcpt70026-sec-0006"><h3 class="pmc_sec_title">2.3. Prostanoids and Endothelial Dysfunction in Hypertension</h3>
<p>Previous studies have shown that endothelium‐derived vasoconstrictor prostanoids are major determinants of endothelial dysfunction in hypertension [<a href="#bcpt70026-bib-0001" class="usa-link" aria-describedby="bcpt70026-bib-0001">1</a>]. A role for constitutive COX‐1 has been described for endothelium‐derived contractile factor (EDCF) production in several animal models, including spontaneously hypertensive rats (SHR) [<a href="#bcpt70026-bib-0001" class="usa-link" aria-describedby="bcpt70026-bib-0001">1</a>]. Moreover, whereas inducible COX‐2 is typically expressed at low levels in healthy blood vessels, its expression is significantly increased in vessels from hypertensive patients and hypertension models, probably due to the inflammatory phenotype. In these conditions, COX‐2 plays a role in endothelial dysfunction, as demonstrated by the fact that selective COX‐2 inhibitors restore impaired vasodilation to acetylcholine and reduce the increased EDCF responses [<a href="#bcpt70026-bib-0001" class="usa-link" aria-describedby="bcpt70026-bib-0001">1</a>, <a href="#bcpt70026-bib-0028" class="usa-link" aria-describedby="bcpt70026-bib-0028">28</a>, <a href="#bcpt70026-bib-0029" class="usa-link" aria-describedby="bcpt70026-bib-0029">29</a>, <a href="#bcpt70026-bib-0039" class="usa-link" aria-describedby="bcpt70026-bib-0039">39</a>]. Prostanoids derived from COX‐2 are considered EDCF in hypertension. For example, vascular PGF<sub>2α</sub> production is increased in hypertension, and the increased endothelium‐dependent contractility is abolished by a thromboxane A<sub>2</sub>/prostaglandin H<sub>2</sub> (TP) receptor antagonist in a COX‐2‐dependent manner [<a href="#bcpt70026-bib-0029" class="usa-link" aria-describedby="bcpt70026-bib-0029">29</a>, <a href="#bcpt70026-bib-0040" class="usa-link" aria-describedby="bcpt70026-bib-0040">40</a>, <a href="#bcpt70026-bib-0041" class="usa-link" aria-describedby="bcpt70026-bib-0041">41</a>]. Interestingly, PGI<sub>2</sub>, which in healthy vessels acts as an important endothelium‐derived relaxing factor via the IP receptor in VSMCs, acts as a TP agonist to induce contraction in arteries from hypertensive animals [<a href="#bcpt70026-bib-0035" class="usa-link" aria-describedby="bcpt70026-bib-0035">35</a>]. In agreement, PGIS deficiency results in the exacerbation or appearance of endothelium‐dependent constriction ex vivo and in vivo together with reduced NO‐dependent relaxation and increased blood pressure [<a href="#bcpt70026-bib-0042" class="usa-link" aria-describedby="bcpt70026-bib-0042">42</a>].</p>
<p>Ang II and increased oxidative stress appear to be major contributors to the upregulation of vascular COX‐2 in hypertension [<a href="#bcpt70026-bib-0029" class="usa-link" aria-describedby="bcpt70026-bib-0029">29</a>, <a href="#bcpt70026-bib-0039" class="usa-link" aria-describedby="bcpt70026-bib-0039">39</a>]. On the other hand, COX‐2 is a major source of vascular oxidative stress in hypertension, either directly through its enzymatic activity or indirectly through the effects of prostanoids in various ROS sources [<a href="#bcpt70026-bib-0028" class="usa-link" aria-describedby="bcpt70026-bib-0028">28</a>, <a href="#bcpt70026-bib-0029" class="usa-link" aria-describedby="bcpt70026-bib-0029">29</a>, <a href="#bcpt70026-bib-0043" class="usa-link" aria-describedby="bcpt70026-bib-0043">43</a>]. Thus, the COX‐2–ROS axis may create a vicious cycle of self‐perpetuating vasoactive substances that play a pathophysiological role in the altered vascular contractile and dilatory responses associated with hypertension [<a href="#bcpt70026-bib-0043" class="usa-link" aria-describedby="bcpt70026-bib-0043">43</a>]. These data suggest that COX‐derived prostanoids may be a pharmacological target for vascular dysfunction in hypertension. However, both selective and non‐selective non‐steroidal anti‐inflammatory drugs increase cardiovascular risk [<a href="#bcpt70026-bib-0044" class="usa-link" aria-describedby="bcpt70026-bib-0044">44</a>]. In this context, inhibition of specific prostanoid‐generating enzymes or receptors may be a safer strategy. For example, microsomal prostaglandin E synthase‐1 (mPGES‐1), an inducible PGE<sub>2</sub>‐generating enzyme downstream COX‐2, is upregulated in the aorta of Ang II‐induced hypertensive mice, and its expression is also upregulated in peripheral blood mononuclear cells from hypertensive patients [<a href="#bcpt70026-bib-0045" class="usa-link" aria-describedby="bcpt70026-bib-0045">45</a>, <a href="#bcpt70026-bib-0046" class="usa-link" aria-describedby="bcpt70026-bib-0046">46</a>]. Furthermore, the deletion of mPGES‐1 or EP1 blockade prevented the Ang II‐induced hypercontractility and endothelial dysfunction [<a href="#bcpt70026-bib-0045" class="usa-link" aria-describedby="bcpt70026-bib-0045">45</a>, <a href="#bcpt70026-bib-0046" class="usa-link" aria-describedby="bcpt70026-bib-0046">46</a>], suggesting a role for this prostanoid in altered endothelial function in hypertension.</p></section></section><section id="bcpt70026-sec-0007"><h2 class="pmc_sec_title">3. Resolution of Inflammation and Endothelial Dysfunction</h2>
<p>Resolution of inflammation is a critical process in tissue repair and restoration of tissue homeostasis. It is a highly orchestrated process mediated by the enzymatic conversion of ω‐6 and ω‐3 polyunsaturated fatty acids (PUFA), including arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), to a family of specialized pro‐resolving mediators [SPMs: lipoxins (LX), resolvins (Rv), protectins, maresins (MaR)] by various enzymes such as 5‐ or 15‐lipoxygenases (5‐LOX, 15‐LOX) [<a href="#bcpt70026-bib-0047" class="usa-link" aria-describedby="bcpt70026-bib-0047">47</a>, <a href="#bcpt70026-bib-0048" class="usa-link" aria-describedby="bcpt70026-bib-0048">48</a>]. The production of SPMs is initiated by a temporal lipid mediator class switch in which COX‐derived PGE<sub>2</sub> precedes the biosynthesis of lipoxins from AA. PGE<sub>2</sub> and PGD<sub>2</sub> induce 15‐LOX in human neutrophils switching from leukotriene B4 to lipoxin production, which is a stop signal for polymorphonuclear neutrophils that limits further recruitment [<a href="#bcpt70026-bib-0047" class="usa-link" aria-describedby="bcpt70026-bib-0047">47</a>, <a href="#bcpt70026-bib-0048" class="usa-link" aria-describedby="bcpt70026-bib-0048">48</a>]. SPMs are also produced by macrophages because they have all the biosynthetic enzymes. Moreover, SPMs are biosynthesized via cell–cell communication in a process termed transcellular biosynthesis [<a href="#bcpt70026-bib-0049" class="usa-link" aria-describedby="bcpt70026-bib-0049">49</a>]. Specifically, activated EC at sites of inflammation produce precursors of SPMs that are taken up by adherent neutrophils and converted into several SPMs [<a href="#bcpt70026-bib-0049" class="usa-link" aria-describedby="bcpt70026-bib-0049">49</a>], confirming the role of EC not only as major targets of inflammatory molecules but as key players in the resolution of inflammation programme. Interestingly, cardiovascular medications such as aspirin or atorvastatin trigger the formation of specific LXs, Rvs and protectins, as well as n‐3 DPA‐derived 13‐series resolvins, which are produced during neutrophil–endothelial cell interactions [<a href="#bcpt70026-bib-0050" class="usa-link" aria-describedby="bcpt70026-bib-0050">50</a>, <a href="#bcpt70026-bib-0051" class="usa-link" aria-describedby="bcpt70026-bib-0051">51</a>].</p>
<p>SPMs bind cognate G protein‐coupled receptors such as ALX/FPR2 for RvD1 and LXA4, GPR32 for RvD1, GPR18 for RvD2, ChemR23 for RvE1, or LGR6 for MaR1, among others [<a href="#bcpt70026-bib-0047" class="usa-link" aria-describedby="bcpt70026-bib-0047">47</a>, <a href="#bcpt70026-bib-0048" class="usa-link" aria-describedby="bcpt70026-bib-0048">48</a>]. These receptors are expressed on various immune cells such as neutrophils, monocytes, macrophages and T cells, where they exert protective functions such as decreased infiltration, chemotaxis and activation, decreased production of inflammatory cytokines, increased efferocytosis and phagocytosis capability and polarization of M2 macrophages. SPM receptors are also expressed on platelets and VSMC and EC, facilitating reduced platelet aggregation and activation, reduced VSMC proliferation and migration, reduced EC activation and reduced expression/activation of proinflammatory pathways [<a href="#bcpt70026-bib-0047" class="usa-link" aria-describedby="bcpt70026-bib-0047">47</a>, <a href="#bcpt70026-bib-0052" class="usa-link" aria-describedby="bcpt70026-bib-0052">52</a>, <a href="#bcpt70026-bib-0053" class="usa-link" aria-describedby="bcpt70026-bib-0053">53</a>]. Overall, this limits immune cell infiltration and initiates tissue repair mechanisms [<a href="#bcpt70026-bib-0047" class="usa-link" aria-describedby="bcpt70026-bib-0047">47</a>, <a href="#bcpt70026-bib-0048" class="usa-link" aria-describedby="bcpt70026-bib-0048">48</a>, <a href="#bcpt70026-bib-0052" class="usa-link" aria-describedby="bcpt70026-bib-0052">52</a>, <a href="#bcpt70026-bib-0053" class="usa-link" aria-describedby="bcpt70026-bib-0053">53</a>, <a href="#bcpt70026-bib-0054" class="usa-link" aria-describedby="bcpt70026-bib-0054">54</a>]. Importantly, lack of resolution of inflammation is a major pathophysiology in common vascular diseases [<a href="#bcpt70026-bib-0052" class="usa-link" aria-describedby="bcpt70026-bib-0052">52</a>, <a href="#bcpt70026-bib-0054" class="usa-link" aria-describedby="bcpt70026-bib-0054">54</a>]. Indeed, dysregulation of SPMs levels, enzymes or receptors has been shown in human atherosclerotic plaques and aortic aneurysms [<a href="#bcpt70026-bib-0055" class="usa-link" aria-describedby="bcpt70026-bib-0055">55</a>, <a href="#bcpt70026-bib-0056" class="usa-link" aria-describedby="bcpt70026-bib-0056">56</a>, <a href="#bcpt70026-bib-0057" class="usa-link" aria-describedby="bcpt70026-bib-0057">57</a>, <a href="#bcpt70026-bib-0058" class="usa-link" aria-describedby="bcpt70026-bib-0058">58</a>, <a href="#bcpt70026-bib-0059" class="usa-link" aria-describedby="bcpt70026-bib-0059">59</a>].</p>
<p>Recent evidence has demonstrated the beneficial effects of SPMs on cardiovascular injury in a variety of conditions by modulating immune cell infiltration and inflammation, as well as cardiovascular remodelling and extracellular matrix deposition [<a href="#bcpt70026-bib-0049" class="usa-link" aria-describedby="bcpt70026-bib-0049">49</a>, <a href="#bcpt70026-bib-0060" class="usa-link" aria-describedby="bcpt70026-bib-0060">60</a>, <a href="#bcpt70026-bib-0061" class="usa-link" aria-describedby="bcpt70026-bib-0061">61</a>, <a href="#bcpt70026-bib-0062" class="usa-link" aria-describedby="bcpt70026-bib-0062">62</a>]. However, the effects of SPMs on endothelial function have been less explored. Initial studies demonstrated that one SPM, RvD2, increased the production of NO and PGI<sub>2</sub> in human umbilical vein EC [<a href="#bcpt70026-bib-0063" class="usa-link" aria-describedby="bcpt70026-bib-0063">63</a>]. In addition, RvD2 activates the PI3K/Akt pathway (which is key to NO production) to regulate the expression of the anti‐inflammatory protein Del‐1 in EC [<a href="#bcpt70026-bib-0064" class="usa-link" aria-describedby="bcpt70026-bib-0064">64</a>]. This may indicate potential effect of SPMs in the modulation of vascular tone. Interestingly, RvD1, RvD2 and RvE1 do not relax preconstricted rat thoracic aortic segments [<a href="#bcpt70026-bib-0065" class="usa-link" aria-describedby="bcpt70026-bib-0065">65</a>], and we have not observed acute relaxant effects of several SPMs in mouse aorta (unpublished). However, RvE1, RvD1 and RvD2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619 [<a href="#bcpt70026-bib-0065" class="usa-link" aria-describedby="bcpt70026-bib-0065">65</a>], and, similarly, pretreatment of isolated human saphenous vein with RvE1, RvD1 and MaR1 significantly reduced the contractile responses to U46619 [<a href="#bcpt70026-bib-0066" class="usa-link" aria-describedby="bcpt70026-bib-0066">66</a>]. Interestingly, pretreatment with LXA4 and RvD2 had no significant effect on the vascular tone of saphenous vein [<a href="#bcpt70026-bib-0066" class="usa-link" aria-describedby="bcpt70026-bib-0066">66</a>], suggesting that there might be differences in SPM responses between arteries and veins.</p>
<section id="bcpt70026-sec-0008"><h3 class="pmc_sec_title">3.1. SPMs and Endothelial Dysfunction in Hypertension</h3>
<p>As discussed above, a major feature of hypertension‐induced endothelial dysfunction is a reduced NO availability. Based on the reported ability of RvD2 to increase NO and PGI<sub>2</sub> [<a href="#bcpt70026-bib-0063" class="usa-link" aria-describedby="bcpt70026-bib-0063">63</a>], we recently tested the effects of RvD2 treatment in vivo in Ang II‐induced hypertension. RvD2 not only prevented but also reversed the impaired endothelium‐dependent relaxation observed in resistance arteries from Ang II‐infused mouse, which may contribute to its antihypertensive effects [<a href="#bcpt70026-bib-0067" class="usa-link" aria-describedby="bcpt70026-bib-0067">67</a>]. Interestingly, in the aorta, we did not observe an improvement in endothelial dysfunction by RvD2, but we did observe a prevention of hypercontractility, suggesting possible differences in RvD2 receptor expression or signalling between vascular beds [<a href="#bcpt70026-bib-0067" class="usa-link" aria-describedby="bcpt70026-bib-0067">67</a>]. The underlying mechanisms responsible for these effects likely include an increase in NO and PGI<sub>2</sub> availability without a change in the EDHF component. However, the contribution of other factors such as reduced vascular infiltration of immune cells or polarization of the macrophages phenotype towards a proresolving one cannot be excluded [<a href="#bcpt70026-bib-0067" class="usa-link" aria-describedby="bcpt70026-bib-0067">67</a>]. In addition, normalized endothelium‐dependent vasodilation and contractility were induced by in vivo RvD2 treatment in a model of hypertension and obesity in both large and small arteries [<a href="#bcpt70026-bib-0059" class="usa-link" aria-describedby="bcpt70026-bib-0059">59</a>]. Similarly, ex vivo incubation with SPMs such as LXA4, RvD1 or RvE1 potentiated acetylcholine‐induced relaxation in small arteries from SHR but failed to abolish acetylcholine‐induced contraction [<a href="#bcpt70026-bib-0068" class="usa-link" aria-describedby="bcpt70026-bib-0068">68</a>]. In cultured EC, RvD2 also decreased the expression of VCAM, MCP‐1, COX‐2 or Nox5 induced by Ang II and IFNγ and restored the decrease in nitrite production induced by Ang II and IL‐6 [<a href="#bcpt70026-bib-0059" class="usa-link" aria-describedby="bcpt70026-bib-0059">59</a>, <a href="#bcpt70026-bib-0067" class="usa-link" aria-describedby="bcpt70026-bib-0067">67</a>], suggesting a direct effect of RvD2 in this cell type. In the saphenous vein, RvE1, RvD1 and MaR1, but not LXA4 and RvD2 pretreatment, reduced the release of MCP‐1 and TNF‐α [<a href="#bcpt70026-bib-0066" class="usa-link" aria-describedby="bcpt70026-bib-0066">66</a>].</p>
<p>The beneficial effects of RvD2 on endothelial function appear to be independent of VSMC sensitivity to NO, as responses to NO donors were similar in hypertensive mice treated or not with RvD2 [<a href="#bcpt70026-bib-0059" class="usa-link" aria-describedby="bcpt70026-bib-0059">59</a>, <a href="#bcpt70026-bib-0067" class="usa-link" aria-describedby="bcpt70026-bib-0067">67</a>]. However, an effect of SPMs in VSMC in hypertension has also been demonstrated, as RvD2 improved vascular structure in lean or obese hypertensive mice [<a href="#bcpt70026-bib-0059" class="usa-link" aria-describedby="bcpt70026-bib-0059">59</a>, <a href="#bcpt70026-bib-0067" class="usa-link" aria-describedby="bcpt70026-bib-0067">67</a>]. Moreover, RvE1 through the ChemR23 receptor ameliorated hypertension and vascular remodelling by activating AMPKα/Nrf2 signalling, which inhibited the canonical NF‐κB/Ccl5 pathway and immune cell infiltration and regulated VSMC proliferation and phenotypic transformation [<a href="#bcpt70026-bib-0069" class="usa-link" aria-describedby="bcpt70026-bib-0069">69</a>]. In addition, RvD1 attenuated Ang II‐induced hypertension by inhibiting VSMC proliferation, migration and phenotypic transformation by blocking the RhoA/MAPK pathway [<a href="#bcpt70026-bib-0070" class="usa-link" aria-describedby="bcpt70026-bib-0070">70</a>]. Taken together, these findings suggest protective effects of SPMs in specific features of endothelial dysfunction and vascular remodelling in hypertension.</p>
<p>As hypertension and endothelial dysfunction often accompany other cardiovascular conditions such as atherosclerosis and aneurysms, we will also discuss the beneficial effects of SPMs in these diseases.</p></section><section id="bcpt70026-sec-0009"><h3 class="pmc_sec_title">3.2. SPMs and Endothelial Dysfunction in Atherosclerosis</h3>
<p>Endothelial dysfunction is an initiating event in atherosclerosis. As mentioned above, chronic exposure to cardiovascular risk factors results in endothelial dysfunction and subsequent increased endothelial permeability, which in turn promotes LDL‐c transcytosis across the endothelium, leading to its accumulation and subsequent oxidation. This process triggers the expression of cell adhesion molecules, including VCAM1 and ICAM1, and selectins by EC, which in turn attract monocytes and lymphocytes into the sub‐endothelial space [<a href="#bcpt70026-bib-0007" class="usa-link" aria-describedby="bcpt70026-bib-0007">7</a>]. Monocytes are converted into macrophages, which express scavenger receptors for modified lipoproteins. The ingestion of lipoproteins by macrophages induces the differentiation of these cells into foam cells, leading to the formation of fatty streaks, the initial lesion of atherosclerosis. Communication between the various cellular components of innate and adaptive immunity increases the release of pro‐inflammatory cytokines, such as MCP‐1, which sustain and amplify the inflammatory response. This chronic inflammatory response at the lesion site serves as a stimulus for the migration and proliferation of VSMCs from the media into the neointima layer, leading to the formation of a fibrous cap over the lipid core and the conversion of the fatty streak into a fibrofatty lesion [<a href="#bcpt70026-bib-0071" class="usa-link" aria-describedby="bcpt70026-bib-0071">71</a>].</p>
<p>The protective effects of activating resolution of inflammation in atherosclerosis have been demonstrated in many landmark studies [<a href="#bcpt70026-bib-0049" class="usa-link" aria-describedby="bcpt70026-bib-0049">49</a>, <a href="#bcpt70026-bib-0051" class="usa-link" aria-describedby="bcpt70026-bib-0051">51</a>, <a href="#bcpt70026-bib-0052" class="usa-link" aria-describedby="bcpt70026-bib-0052">52</a>, <a href="#bcpt70026-bib-0054" class="usa-link" aria-describedby="bcpt70026-bib-0054">54</a>, <a href="#bcpt70026-bib-0060" class="usa-link" aria-describedby="bcpt70026-bib-0060">60</a>]. Regarding specific features of endothelial dysfunction, several reports demonstrate that SPMs reduce EC activation, inflammation and oxidative stress. For example, RvE1 downregulated the local expression of pro‐atherogenic genes involved in cell adhesion such as Cd74, Cd44, Ccl2 or Ccr5 in the aorta and significantly inactivated IFN‐γ and TNF‐α signalling pathways in ApoE*3Leiden mice fed a hypercholesterolaemic diet [<a href="#bcpt70026-bib-0072" class="usa-link" aria-describedby="bcpt70026-bib-0072">72</a>]. In fat‐fed Ldlr<sup>−/−</sup> mice, administration of RvD1 during plaque progression promotes plaque stability, reduces lesional oxidative stress and necrosis, improves lesional efferocytosis and thickens fibrous caps [<a href="#bcpt70026-bib-0055" class="usa-link" aria-describedby="bcpt70026-bib-0055">55</a>]. Aspirin‐triggered LXA4 blocked atherosclerosis progression in the aortic root and thoracic aorta of ApoE<sup>−/−</sup> mice, reduced macrophage infiltration and apoptotic cells in atherosclerotic lesions and decreased the mRNA levels of several cytokines and chemokines (CCL2 and CXCL16) in the spleen and aorta [<a href="#bcpt70026-bib-0073" class="usa-link" aria-describedby="bcpt70026-bib-0073">73</a>]. In addition, diabetes‐induced aortic plaque development and aortic tissue inflammation, including VCAM‐1, MCP‐1, IL‐6 and IL‐1β expression, were significantly attenuated by both LXA4 and a synthetic LX analogue, Benzo‐LXA4 [<a href="#bcpt70026-bib-0074" class="usa-link" aria-describedby="bcpt70026-bib-0074">74</a>]. On the other hand, RvD2 and MaR 1 treatment does not significantly affect endothelial ICAM‐1 and VCAM‐1 expression in ApoE<sup>−/−</sup> mice fed a high‐fat diet for 4 months [<a href="#bcpt70026-bib-0075" class="usa-link" aria-describedby="bcpt70026-bib-0075">75</a>]. These findings suggest that SPMs might be protective in the early stages of atherosclerosis by improving endothelial function. Furthermore, an additional contribution of the immune cell modulation induced by SPMs cannot be excluded. Indeed, a protective role of several SPMs receptors specifically expressed in macrophages has been demonstrated in atherosclerosis [<a href="#bcpt70026-bib-0057" class="usa-link" aria-describedby="bcpt70026-bib-0057">57</a>, <a href="#bcpt70026-bib-0076" class="usa-link" aria-describedby="bcpt70026-bib-0076">76</a>, <a href="#bcpt70026-bib-0077" class="usa-link" aria-describedby="bcpt70026-bib-0077">77</a>, <a href="#bcpt70026-bib-0078" class="usa-link" aria-describedby="bcpt70026-bib-0078">78</a>]. Most likely, the protective effects of SPMs in vivo involve multiple cell types, which also represent very exciting pharmacological perspectives to reprogramme the immune response with additional protective vascular effects.</p></section><section id="bcpt70026-sec-0010"><h3 class="pmc_sec_title">3.3. SPMs and Endothelial Dysfunction in Abdominal Aortic Aneurysm</h3>
<p>Atherosclerosis and abdominal aortic aneurysm (AAA) share several risk factors and aetiopathogenic mechanisms [<a href="#bcpt70026-bib-0079" class="usa-link" aria-describedby="bcpt70026-bib-0079">79</a>]. However, although endothelial dysfunction is a critical feature of atherosclerotic disease, its contribution to AAA has been somewhat underestimated and insufficiently investigated. In patients with AAA, endothelial function, measured as endothelium‐dependent flow‐mediated vasodilation, is negatively correlated with aneurysm diameter, whereas it is improved after surgical repair [<a href="#bcpt70026-bib-0080" class="usa-link" aria-describedby="bcpt70026-bib-0080">80</a>, <a href="#bcpt70026-bib-0081" class="usa-link" aria-describedby="bcpt70026-bib-0081">81</a>], suggesting a close relationship between endothelial dysfunction and AAA. Indeed, major risk factors for the development of AAA, such as smoking, ageing or hypertension, are closely associated with endothelial dysfunction, and therefore, many features of endothelial dysfunction are also found in AAA. For example, decreased NO bioavailability has received increasing attention as a critical player in the development of AAA, and the association between AAA, impaired NO bioavailability, oxidative stress and endothelial NADPH oxidases and inflammation has been extensively explored, postulating new therapeutic strategies for AAA [<a href="#bcpt70026-bib-0079" class="usa-link" aria-describedby="bcpt70026-bib-0079">79</a>, <a href="#bcpt70026-bib-0082" class="usa-link" aria-describedby="bcpt70026-bib-0082">82</a>, <a href="#bcpt70026-bib-0083" class="usa-link" aria-describedby="bcpt70026-bib-0083">83</a>]. With regard to SPMs, a protective role of the ALX/FPR2 receptor pathway has been proposed in the progression of AAA [<a href="#bcpt70026-bib-0056" class="usa-link" aria-describedby="bcpt70026-bib-0056">56</a>]. Moreover, several studies have shown that treatment with RvD2, RvD1 or MaR1 protects against AAA in various animal models, in particular by reducing inflammation and oxidative stress and modulating the phenotype of macrophages towards a proresolving one [<a href="#bcpt70026-bib-0084" class="usa-link" aria-describedby="bcpt70026-bib-0084">84</a>, <a href="#bcpt70026-bib-0085" class="usa-link" aria-describedby="bcpt70026-bib-0085">85</a>, <a href="#bcpt70026-bib-0086" class="usa-link" aria-describedby="bcpt70026-bib-0086">86</a>, <a href="#bcpt70026-bib-0087" class="usa-link" aria-describedby="bcpt70026-bib-0087">87</a>, <a href="#bcpt70026-bib-0088" class="usa-link" aria-describedby="bcpt70026-bib-0088">88</a>]. Unfortunately, endothelial (dys)function was not assessed in these studies. In this context, we have recently reported that in a model of aortic dilation induced by high‐fat diet plus hypertension by Ang II infusion, RvD2 not only prevented the impaired endothelium‐dependent relaxation and the altered contractility of aortic segments but also improved endothelial function in small mesenteric arteries, and these effects were associated with reduced expression of some proinflammatory markers [<a href="#bcpt70026-bib-0059" class="usa-link" aria-describedby="bcpt70026-bib-0059">59</a>]. These results suggest that the beneficial effects of SPM in AAA might be due not only to effects on inflammation and VSMC, but also on endothelial function. Future studies are needed to further investigate the potential of resolution of inflammation in endothelial dysfunction in this devastating disease.</p></section></section><section id="bcpt70026-sec-0011"><h2 class="pmc_sec_title">4. Targeting Inflammation in Endothelial Dysfunction and Cardiovascular Disease in Humans</h2>
<p>As discussed above, inflammation is a major contributor to endothelial dysfunction in hypertension. Drugs used to treat hypertension are also associated with a reduced inflammatory response in the vasculature [<a href="#bcpt70026-bib-0089" class="usa-link" aria-describedby="bcpt70026-bib-0089">89</a>]. However, patients who achieve adequate blood pressure control still have an increased risk of cardiovascular events compared with their untreated counterparts with similar levels of blood pressure [<a href="#bcpt70026-bib-0090" class="usa-link" aria-describedby="bcpt70026-bib-0090">90</a>]. A possible explanation for this residual risk is that the inflammatory response is undertreated in these hypertensive patients. Anti‐inflammatory or immunomodulatory approaches are not currently considered therapeutic options for reducing blood pressure and associated cardiovascular disease. However, targeting inflammation could lead to a reduction in cardiovascular events in hypertensive patients, probably by improving vascular function. Several studies have shown that statins have beneficial effects on endothelial function, possibly attributed to their antioxidant and anti‐inflammatory properties rather than their lipid‐lowering effects [<a href="#bcpt70026-bib-0091" class="usa-link" aria-describedby="bcpt70026-bib-0091">91</a>, <a href="#bcpt70026-bib-0092" class="usa-link" aria-describedby="bcpt70026-bib-0092">92</a>]. In addition, clinical trials such as CANTOS (Canakinumab Anti‐inflammatory Thrombosis Outcomes Study) or LoDoCo2 (Low Dose Colchicine‐2) have shown that antiinflammatory therapies such as canakinumab, a monoclonal antibody targeting IL‐1β, or colchicine, a broad anti‐inflammatory drug, reduce cardiovascular events [<a href="#bcpt70026-bib-0093" class="usa-link" aria-describedby="bcpt70026-bib-0093">93</a>, <a href="#bcpt70026-bib-0094" class="usa-link" aria-describedby="bcpt70026-bib-0094">94</a>]. Of note, inflammation assessed by high‐sensitivity CRP was a stronger predictor for risk of future cardiovascular events and death than cholesterol assessed by LDL‐C [<a href="#bcpt70026-bib-0095" class="usa-link" aria-describedby="bcpt70026-bib-0095">95</a>]. These data suggest that inflammation‐inhibiting therapies may be needed to further reduce cardiovascular mortality. However, some of these therapies can induce immunosuppression, and they should preserve tissue repair but also maintain the immune physiological response.</p>
<p>Over the past decades, numerous studies have investigated the role of ω‐3 PUFA in CVD. Cardiovascular outcome trials on ω‐3 fatty acids have generated contradictory results likely due to the heterogeneity of the study population, the proportion of the two ω‐3 PUFA, EPA and DHA, and the formulation of the ω‐3 PUFA used, as well as the relatively low dose used in most trials (up to approximately 1 g ω‐3 PUFA) [<a href="#bcpt70026-bib-0062" class="usa-link" aria-describedby="bcpt70026-bib-0062">62</a>]. Several clinical trials such as JELIS (Japan EPA Lipid Intervention), REDUCE‐IT (Reduction of Cardiovascular Events with Icosapent Ethyl Intervention Trial) or EVAPORATE (Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy) have shown that treatment of patients with either EPA or the purified ethyl ester of EPA resulted in reduced clinical cardiac events and significant plaque regression [<a href="#bcpt70026-bib-0096" class="usa-link" aria-describedby="bcpt70026-bib-0096">96</a>, <a href="#bcpt70026-bib-0097" class="usa-link" aria-describedby="bcpt70026-bib-0097">97</a>, <a href="#bcpt70026-bib-0098" class="usa-link" aria-describedby="bcpt70026-bib-0098">98</a>]. The underlying mechanisms appear to include more than just triglycerides lowering such as modulation of endothelial function, attenuation of intraplaque inflammation and oxidative stress, and reduction of macrophage accumulation that can result in plaque stabilization [<a href="#bcpt70026-bib-0062" class="usa-link" aria-describedby="bcpt70026-bib-0062">62</a>, <a href="#bcpt70026-bib-0099" class="usa-link" aria-describedby="bcpt70026-bib-0099">99</a>]. As mentioned, EPA is the precursor of E‐series resolvins, which have antiinflammatory and vasoprotective effects in a number of CVDs such as atherosclerosis, AAA, obesity, hypertension and heart failure. Whether the beneficial effects of ω‐3 fatty acids may be partially due to SPMs is still under investigation.</p></section><section id="bcpt70026-sec-0012"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>Since the seminal observations of Robert Furchgott on the importance of the endothelium for vasodilator responses and the many findings demonstrating the presence of endothelial dysfunction in various CVD [<a href="#bcpt70026-bib-0001" class="usa-link" aria-describedby="bcpt70026-bib-0001">1</a>], efforts have focused on elucidating the underlying mechanisms responsible for EC damage. Proinflammatory cytokines such as ILs, IFNs or TNF‐α, produced by circulating or locally infiltrated immune cells, are elevated in hypertension and other CVD and reduce NO availability through multiple processes including excessive oxidative stress, eNOS uncoupling, production of vasoconstrictor prostanoids or activation of EC that attract and retain leucocytes that further perpetuate endothelial damage. Antihypertensive and lipid‐lowering drugs improve endothelial function, which may be due, at least in part, to their pleiotropic anti‐inflammatory effects. However, many patients remain at residual cardiovascular risk despite effective pharmacological treatment. Strong evidence demonstrate that some anti‐inflammatory drugs can provide further reduction in cardiovascular events, but they should also preserve the physiological immune response. In this sense, recent studies with specific formulations of ω‐3 PUFA have shown beneficial effects on cardiovascular outcomes, probably through effects on vascular and immune cells. SPMs are a family of lipid mediators derived from of ω‐6 and ω‐3 PUFA, that protect EC and VSMC and reprogram immune cells to exert beneficial effects in vascular function in hypertension and other CVD such as atherosclerosis and AAA. As we learn more about the biology of SPMs, the interest of these compounds as therapeutic strategies to preserve endothelial function and treat cardiovascular disease is an area of active research.</p></section><section id="bcpt70026-sec-0014"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="bcpt70026-sec-0013" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Work from the author's laboratory was supported by grants SAF2016‐80305P and PID2020‐116498RB‐I00, funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) and by ‘ERDF A way of making Europe’; Comunidad de Madrid (B2017/BMD‐3676 AORTASANA) FEDER‐a way to build Europe; Fundación Española de Arteriosclerosis (Beca FEA 2021 Investigación Básica en Arteriosclerosis); CiberCV Instituto de Salud Carlos III (CiberCV CB16/11/00286, CiberCV CB16/11/00257, CiberCV CB16/11/00333 and CiberCV CB/11/00222); the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska‐Curie grant agreement no. 954798; and Instituto de Salud Carlos III (AC23_2/00044) under the umbrella of the Partnership Fostering a European Research Area for Health (ERA4Health) (GA N° 101095426 of the EU Horizon Europe Research and Innovation Programme).</p></section><section id="notes1"><section id="bcpt70026-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="bcpt70026-note-0001"><p>
<strong>Funding:</strong> Work from the author's laboratory was supported by grants SAF2016‐80305P and PID2020‐116498RB‐I00 funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) and by ‘ERDF A way of making Europe’; Comunidad de Madrid (B2017/BMD‐3676 AORTASANA) FEDER‐a way to build Europe; Fundación Española de Arteriosclerosis (Beca FEA 2021 Investigación Básica en Arteriosclerosis), CiberCV Instituto de Salud Carlos III (CiberCV CB16/11/00286, CiberCV CB16/11/00257, CiberCV CB16/11/00333; CiberCV CB/11/00222); the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska‐Curie grant agreement no. 954798; and Instituto de Salud Carlos III (AC23_2/00044) under the umbrella of the Partnership Fostering a European Research Area for Health (ERA4Health) (GA N° 101095426 of the EU Horizon Europe Research and Innovation Programme).</p></div></div></section></section><section id="bcpt70026-sec-0016"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data sharing not applicable to this article as no datasets were generated or analysed during the current study.</p></section><section id="bcpt70026-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="bcpt70026-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bcpt70026-bib-0001">
<span class="label">1.</span><cite>
Vanhoutte P. M., Shimokawa H., Feletou M., and Tang E. H., “Endothelial Dysfunction and Vascular Disease ‐ A 30th Anniversary Update,” Acta Physiologica (Oxford, England)
219, no. 1 (2017): 22–96, 10.1111/apha.12646.
</cite> [<a href="https://doi.org/10.1111/apha.12646" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26706498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Physiologica%20(Oxford,%20England)&amp;title=Endothelial%20Dysfunction%20and%20Vascular%20Disease%20%E2%80%90%20A%2030th%20Anniversary%20Update&amp;author=P.%20M.%20Vanhoutte&amp;author=H.%20Shimokawa&amp;author=M.%20Feletou&amp;author=E.%20H.%20Tang&amp;volume=219&amp;issue=1&amp;publication_year=2017&amp;pages=22-96&amp;pmid=26706498&amp;doi=10.1111/apha.12646&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0002">
<span class="label">2.</span><cite>
Xu S., Ilyas I., Little P. J., et al., “Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies,” Pharmacological Reviews
73, no. 3 (2021): 924–967, 10.1124/pharmrev.120.000096.
</cite> [<a href="https://doi.org/10.1124/pharmrev.120.000096" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34088867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacological%20Reviews&amp;title=Endothelial%20Dysfunction%20in%20Atherosclerotic%20Cardiovascular%20Diseases%20and%20Beyond:%20From%20Mechanism%20to%20Pharmacotherapies&amp;author=S.%20Xu&amp;author=I.%20Ilyas&amp;author=P.%20J.%20Little&amp;volume=73&amp;issue=3&amp;publication_year=2021&amp;pages=924-967&amp;pmid=34088867&amp;doi=10.1124/pharmrev.120.000096&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0003">
<span class="label">3.</span><cite>
Alexander Y., Osto E., Schmidt‐Trucksäss A., et al., “Endothelial Function in Cardiovascular Medicine: A Consensus Paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis,” Cardiovascular Research
117, no. 1 (2021): 29–42, 10.1093/cvr/cvaa085.
</cite> [<a href="https://doi.org/10.1093/cvr/cvaa085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7797212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32282914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Endothelial%20Function%20in%20Cardiovascular%20Medicine:%20A%20Consensus%20Paper%20of%20the%20European%20Society%20of%20Cardiology%20Working%20Groups%20on%20Atherosclerosis%20and%20Vascular%20Biology,%20Aorta%20and%20Peripheral%20Vascular%20Diseases,%20Coronary%20Pathophysiology%20and%20Microcirculation,%20and%20Thrombosis&amp;author=Y.%20Alexander&amp;author=E.%20Osto&amp;author=A.%20Schmidt%E2%80%90Trucks%C3%A4ss&amp;volume=117&amp;issue=1&amp;publication_year=2021&amp;pages=29-42&amp;pmid=32282914&amp;doi=10.1093/cvr/cvaa085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0004">
<span class="label">4.</span><cite>
Guzik T. J., Nosalski R., Maffia P., and Drummond G. R., “Immune and Inflammatory Mechanisms in Hypertension,” Nature Reviews. Cardiology
21, no. 6 (2024): 396–416, 10.1038/s41569-023-00964-1.
</cite> [<a href="https://doi.org/10.1038/s41569-023-00964-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38172242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Cardiology&amp;title=Immune%20and%20Inflammatory%20Mechanisms%20in%20Hypertension&amp;author=T.%20J.%20Guzik&amp;author=R.%20Nosalski&amp;author=P.%20Maffia&amp;author=G.%20R.%20Drummond&amp;volume=21&amp;issue=6&amp;publication_year=2024&amp;pages=396-416&amp;pmid=38172242&amp;doi=10.1038/s41569-023-00964-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0005">
<span class="label">5.</span><cite>
Ait‐Oufella H. and Libby P., “Inflammation and Atherosclerosis: Prospects for Clinical Trials,” Arteriosclerosis, Thrombosis, and Vascular Biology
44, no. 9 (2024): 1899–1905, 10.1161/ATVBAHA.124.320155.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.124.320155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11343092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39167675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,%20Thrombosis,%20and%20Vascular%20Biology&amp;title=Inflammation%20and%20Atherosclerosis:%20Prospects%20for%20Clinical%20Trials&amp;author=H.%20Ait%E2%80%90Oufella&amp;author=P.%20Libby&amp;volume=44&amp;issue=9&amp;publication_year=2024&amp;pages=1899-1905&amp;pmid=39167675&amp;doi=10.1161/ATVBAHA.124.320155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0006">
<span class="label">6.</span><cite>
Perticone F., Ceravolo R., Pujia A., et al., “Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients,” Circulation
104, no. 2 (2001): 191–196, 10.1161/01.cir.104.2.191.
</cite> [<a href="https://doi.org/10.1161/01.cir.104.2.191" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11447085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Prognostic%20Significance%20of%20Endothelial%20Dysfunction%20in%20Hypertensive%20Patients&amp;author=F.%20Perticone&amp;author=R.%20Ceravolo&amp;author=A.%20Pujia&amp;volume=104&amp;issue=2&amp;publication_year=2001&amp;pages=191-196&amp;pmid=11447085&amp;doi=10.1161/01.cir.104.2.191&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0007">
<span class="label">7.</span><cite>
Kita T., Kume N., Minami M., et al., “Role of Oxidized LDL in Atherosclerosis,” Annals of the New York Academy of Sciences
947 (2001): 199–206, 10.1111/j.1749-6632.2001.tb03941.x.
</cite> [<a href="https://doi.org/10.1111/j.1749-6632.2001.tb03941.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11795267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&amp;title=Role%20of%20Oxidized%20LDL%20in%20Atherosclerosis&amp;author=T.%20Kita&amp;author=N.%20Kume&amp;author=M.%20Minami&amp;volume=947&amp;publication_year=2001&amp;pages=199-206&amp;pmid=11795267&amp;doi=10.1111/j.1749-6632.2001.tb03941.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0008">
<span class="label">8.</span><cite>
Sollinger D., Eißler R., Lorenz S., et al., “Damage‐Associated Molecular Pattern Activated Toll‐Like Receptor 4 Signalling Modulates Blood Pressure in L‐NAME‐Induced Hypertension,” Cardiovascular Research
101, no. 3 (2014): 464–472, 10.1093/cvr/cvt265.
</cite> [<a href="https://doi.org/10.1093/cvr/cvt265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24302630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Damage%E2%80%90Associated%20Molecular%20Pattern%20Activated%20Toll%E2%80%90Like%20Receptor%204%20Signalling%20Modulates%20Blood%20Pressure%20in%20L%E2%80%90NAME%E2%80%90Induced%20Hypertension&amp;author=D.%20Sollinger&amp;author=R.%20Ei%C3%9Fler&amp;author=S.%20Lorenz&amp;volume=101&amp;issue=3&amp;publication_year=2014&amp;pages=464-472&amp;pmid=24302630&amp;doi=10.1093/cvr/cvt265&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0009">
<span class="label">9.</span><cite>
Hernanz R., Martínez‐Revelles S., Palacios R., et al., “Toll‐Like Receptor 4 Contributes to Vascular Remodelling and Endothelial Dysfunction in Angiotensin II‐Induced Hypertension,” British Journal of Pharmacology
172, no. 12 (2015): 3159–3176, 10.1111/bph.13117.
</cite> [<a href="https://doi.org/10.1111/bph.13117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4459031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25712370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Toll%E2%80%90Like%20Receptor%204%20Contributes%20to%20Vascular%20Remodelling%20and%20Endothelial%20Dysfunction%20in%20Angiotensin%20II%E2%80%90Induced%20Hypertension&amp;author=R.%20Hernanz&amp;author=S.%20Mart%C3%ADnez%E2%80%90Revelles&amp;author=R.%20Palacios&amp;volume=172&amp;issue=12&amp;publication_year=2015&amp;pages=3159-3176&amp;pmid=25712370&amp;doi=10.1111/bph.13117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0010">
<span class="label">10.</span><cite>
Dos Passos R. R., Santos C. V., Priviero F., et al., “Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective,” Hypertension
81, no. 7 (2024): 1411–1423, 10.1161/HYPERTENSIONAHA.124.21712.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.124.21712" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11168883/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38686582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Immunomodulatory%20Activity%20of%20Cytokines%20in%20Hypertension:%20A%20Vascular%20Perspective&amp;author=R.%20R.%20Dos%20Passos&amp;author=C.%20V.%20Santos&amp;author=F.%20Priviero&amp;volume=81&amp;issue=7&amp;publication_year=2024&amp;pages=1411-1423&amp;pmid=38686582&amp;doi=10.1161/HYPERTENSIONAHA.124.21712&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0011">
<span class="label">11.</span><cite>
Verma M. K., Jaiswal A., Sharma P., Kumar P., and Singh A. N., “Oxidative Stress and Biomarker of TNF‐Alpha, MDA and FRAP in Hypertension,” Journal of Medicine and Life
12 (2019): 253–259, 10.25122/jml-2019-0031.
</cite> [<a href="https://doi.org/10.25122/jml-2019-0031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6814874/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31666827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Medicine%20and%20Life&amp;title=Oxidative%20Stress%20and%20Biomarker%20of%20TNF%E2%80%90Alpha,%20MDA%20and%20FRAP%20in%20Hypertension&amp;author=M.%20K.%20Verma&amp;author=A.%20Jaiswal&amp;author=P.%20Sharma&amp;author=P.%20Kumar&amp;author=A.%20N.%20Singh&amp;volume=12&amp;publication_year=2019&amp;pages=253-259&amp;pmid=31666827&amp;doi=10.25122/jml-2019-0031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0012">
<span class="label">12.</span><cite>
Neumann P., Gertzberg N., and Johnson A., “TNF‐Alpha Induces a Decrease in eNOS Promoter Activity,” American Journal of Physiology. Lung Cellular and Molecular Physiology
286 (2004): L452–L459, 10.1152/ajplung.00378.2002.
</cite> [<a href="https://doi.org/10.1152/ajplung.00378.2002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14555463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology.%20Lung%20Cellular%20and%20Molecular%20Physiology&amp;title=TNF%E2%80%90Alpha%20Induces%20a%20Decrease%20in%20eNOS%20Promoter%20Activity&amp;author=P.%20Neumann&amp;author=N.%20Gertzberg&amp;author=A.%20Johnson&amp;volume=286&amp;publication_year=2004&amp;pages=L452-L459&amp;pmid=14555463&amp;doi=10.1152/ajplung.00378.2002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0013">
<span class="label">13.</span><cite>
Dhawan S., Singh S., and Aggarwal B. B., “Induction of Endothelial Cell Surface Adhesion Molecules by Tumor Necrosis Factor Is Blocked by Protein Tyrosine Phosphatase Inhibitors: Role of the Nuclear Transcription Factor NF‐Kappa B,” European Journal of Immunology
27 (1997): 2172–2179, 10.1002/eji.1830270909.
</cite> [<a href="https://doi.org/10.1002/eji.1830270909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9341756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Immunology&amp;title=Induction%20of%20Endothelial%20Cell%20Surface%20Adhesion%20Molecules%20by%20Tumor%20Necrosis%20Factor%20Is%20Blocked%20by%20Protein%20Tyrosine%20Phosphatase%20Inhibitors:%20Role%20of%20the%20Nuclear%20Transcription%20Factor%20NF%E2%80%90Kappa%20B&amp;author=S.%20Dhawan&amp;author=S.%20Singh&amp;author=B.%20B.%20Aggarwal&amp;volume=27&amp;publication_year=1997&amp;pages=2172-2179&amp;pmid=9341756&amp;doi=10.1002/eji.1830270909&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0014">
<span class="label">14.</span><cite>
Hung M. J., Cherng W. J., Hung M. Y., Wu H. T., and Pang J. H., “Interleukin‐6 Inhibits Endothelial Nitric Oxide Synthase Activation and Increases Endothelial Nitric Oxide Synthase Binding to Stabilized Caveolin‐1 in Human Vascular Endothelial Cells,” Journal of Hypertension
28 (2010): 940–951, 10.1097/HJH.0b013e32833992ef.
</cite> [<a href="https://doi.org/10.1097/HJH.0b013e32833992ef" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20375905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hypertension&amp;title=Interleukin%E2%80%906%20Inhibits%20Endothelial%20Nitric%20Oxide%20Synthase%20Activation%20and%20Increases%20Endothelial%20Nitric%20Oxide%20Synthase%20Binding%20to%20Stabilized%20Caveolin%E2%80%901%20in%20Human%20Vascular%20Endothelial%20Cells&amp;author=M.%20J.%20Hung&amp;author=W.%20J.%20Cherng&amp;author=M.%20Y.%20Hung&amp;author=H.%20T.%20Wu&amp;author=J.%20H.%20Pang&amp;volume=28&amp;publication_year=2010&amp;pages=940-951&amp;pmid=20375905&amp;doi=10.1097/HJH.0b013e32833992ef&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0015">
<span class="label">15.</span><cite>
Schrader L. I., Kinzenbaw D. A., Johnson A. W., Faraci F. M., and Didion S. P., “IL‐6 Deficiency Protects Against Angiotensin II Induced Endothelial Dysfunction and Hypertrophy,” Arteriosclerosis, Thrombosis, and Vascular Biology
27 (2007): 2576–2581, 10.1161/ATVBAHA.107.153080.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.107.153080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17962626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arteriosclerosis,%20Thrombosis,%20and%20Vascular%20Biology&amp;title=IL%E2%80%906%20Deficiency%20Protects%20Against%20Angiotensin%20II%20Induced%20Endothelial%20Dysfunction%20and%20Hypertrophy&amp;author=L.%20I.%20Schrader&amp;author=D.%20A.%20Kinzenbaw&amp;author=A.%20W.%20Johnson&amp;author=F.%20M.%20Faraci&amp;author=S.%20P.%20Didion&amp;volume=27&amp;publication_year=2007&amp;pages=2576-2581&amp;pmid=17962626&amp;doi=10.1161/ATVBAHA.107.153080&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0016">
<span class="label">16.</span><cite>
Jimenez‐Altayo F., Briones A. M., Giraldo J., Planas A. M., Salaices M., and Vila E., “Increased Superoxide Anion Production by Interleukin‐1Beta Impairs Nitric Oxide‐Mediated Relaxation in Resistance Arteries,” Journal of Pharmacology and Experimental Therapeutics
316 (2006): 42–52, 10.1124/jpet.105.088435.
</cite> [<a href="https://doi.org/10.1124/jpet.105.088435" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16183707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=Increased%20Superoxide%20Anion%20Production%20by%20Interleukin%E2%80%901Beta%20Impairs%20Nitric%20Oxide%E2%80%90Mediated%20Relaxation%20in%20Resistance%20Arteries&amp;author=F.%20Jimenez%E2%80%90Altayo&amp;author=A.%20M.%20Briones&amp;author=J.%20Giraldo&amp;author=A.%20M.%20Planas&amp;author=M.%20Salaices&amp;volume=316&amp;publication_year=2006&amp;pages=42-52&amp;pmid=16183707&amp;doi=10.1124/jpet.105.088435&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0017">
<span class="label">17.</span><cite>
Dorrance A. M., “Interleukin 1‐Beta (IL‐1β) Enhances Contractile Responses in Endothelium‐Denuded Aorta From Hypertensive, but Not Normotensive, Rats,” Vascular Pharmacology
47 (2007): 160–165, 10.1016/j.vph.2007.05.007.
</cite> [<a href="https://doi.org/10.1016/j.vph.2007.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2000828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17602892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vascular%20Pharmacology&amp;title=Interleukin%201%E2%80%90Beta%20(IL%E2%80%901%CE%B2)%20Enhances%20Contractile%20Responses%20in%20Endothelium%E2%80%90Denuded%20Aorta%20From%20Hypertensive,%20but%20Not%20Normotensive,%20Rats&amp;author=A.%20M.%20Dorrance&amp;volume=47&amp;publication_year=2007&amp;pages=160-165&amp;pmid=17602892&amp;doi=10.1016/j.vph.2007.05.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0018">
<span class="label">18.</span><cite>
Bruder‐Nascimento T., Ferreira N. S., Zanotto C. Z., et al., “NLRP3 Inflammasome Mediates Aldosterone‐Induced Vascular Damage,” Circulation
134, no. 23 (2016): 1866–1880, 10.1161/CIRCULATIONAHA.116.024369.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.116.024369" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27803035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=NLRP3%20Inflammasome%20Mediates%20Aldosterone%E2%80%90Induced%20Vascular%20Damage&amp;author=T.%20Bruder%E2%80%90Nascimento&amp;author=N.%20S.%20Ferreira&amp;author=C.%20Z.%20Zanotto&amp;volume=134&amp;issue=23&amp;publication_year=2016&amp;pages=1866-1880&amp;pmid=27803035&amp;doi=10.1161/CIRCULATIONAHA.116.024369&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0019">
<span class="label">19.</span><cite>
Olivencia M. A., Martinez‐Casales M., Peraza D. A., et al., “K(V) 1.3 Channels Are Novel Determinants of Macrophage‐Dependent Endothelial Dysfunction in Angiotensin II‐Induced Hypertension in Mice,” British Journal of Pharmacology
178 (2021): 1836–1854, 10.1111/bph.15407.
</cite> [<a href="https://doi.org/10.1111/bph.15407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33556997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=K(V)%201.3%20Channels%20Are%20Novel%20Determinants%20of%20Macrophage%E2%80%90Dependent%20Endothelial%20Dysfunction%20in%20Angiotensin%20II%E2%80%90Induced%20Hypertension%20in%20Mice&amp;author=M.%20A.%20Olivencia&amp;author=M.%20Martinez%E2%80%90Casales&amp;author=D.%20A.%20Peraza&amp;volume=178&amp;publication_year=2021&amp;pages=1836-1854&amp;pmid=33556997&amp;doi=10.1111/bph.15407&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0020">
<span class="label">20.</span><cite>
Sun X. N., Li C., Liu Y., et al., “T‐Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon‐Gamma,” Circulation Research
120 (2017): 1584–1597, 10.1161/CIRCRESAHA.116.310480.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.116.310480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28298295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=T%E2%80%90Cell%20Mineralocorticoid%20Receptor%20Controls%20Blood%20Pressure%20by%20Regulating%20Interferon%E2%80%90Gamma&amp;author=X.%20N.%20Sun&amp;author=C.%20Li&amp;author=Y.%20Liu&amp;volume=120&amp;publication_year=2017&amp;pages=1584-1597&amp;pmid=28298295&amp;doi=10.1161/CIRCRESAHA.116.310480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0021">
<span class="label">21.</span><cite>
Benson L. N. and Mu S., “Interferon Gamma in the Pathogenesis of Hypertension ‐ Recent Insights,” Current Opinion in Nephrology and Hypertension
33 (2024): 154–160, 10.1097/MNH.0000000000000966.
</cite> [<a href="https://doi.org/10.1097/MNH.0000000000000966" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10842676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38164939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Nephrology%20and%20Hypertension&amp;title=Interferon%20Gamma%20in%20the%20Pathogenesis%20of%20Hypertension%20%E2%80%90%20Recent%20Insights&amp;author=L.%20N.%20Benson&amp;author=S.%20Mu&amp;volume=33&amp;publication_year=2024&amp;pages=154-160&amp;pmid=38164939&amp;doi=10.1097/MNH.0000000000000966&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0022">
<span class="label">22.</span><cite>
Gonzalez‐Amor M., Garcia‐Redondo A. B., Jorge I., et al., “Interferon‐Stimulated Gene 15 Pathway Is a Novel Mediator of Endothelial Dysfunction and Aneurysms Development in Angiotensin II Infused Mice Through Increased Oxidative Stress,” Cardiovascular Research
118 (2022): 3250–3268, 10.1093/cvr/cvab321.
</cite> [<a href="https://doi.org/10.1093/cvr/cvab321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9799052/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34672341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Interferon%E2%80%90Stimulated%20Gene%2015%20Pathway%20Is%20a%20Novel%20Mediator%20of%20Endothelial%20Dysfunction%20and%20Aneurysms%20Development%20in%20Angiotensin%20II%20Infused%20Mice%20Through%20Increased%20Oxidative%20Stress&amp;author=M.%20Gonzalez%E2%80%90Amor&amp;author=A.%20B.%20Garcia%E2%80%90Redondo&amp;author=I.%20Jorge&amp;volume=118&amp;publication_year=2022&amp;pages=3250-3268&amp;pmid=34672341&amp;doi=10.1093/cvr/cvab321&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0023">
<span class="label">23.</span><cite>
Nguyen H., Chiasson V. L., Chatterjee P., Kopriva S. E., Young K. J., and Mitchell B. M., “Interleukin‐17 Causes Rho‐Kinase‐Mediated Endothelial Dysfunction and Hypertension,” Cardiovascular Research
97, no. 4 (2013): 696–704, 10.1093/cvr/cvs422.
</cite> [<a href="https://doi.org/10.1093/cvr/cvs422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3583258/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23263331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Interleukin%E2%80%9017%20Causes%20Rho%E2%80%90Kinase%E2%80%90Mediated%20Endothelial%20Dysfunction%20and%20Hypertension&amp;author=H.%20Nguyen&amp;author=V.%20L.%20Chiasson&amp;author=P.%20Chatterjee&amp;author=S.%20E.%20Kopriva&amp;author=K.%20J.%20Young&amp;volume=97&amp;issue=4&amp;publication_year=2013&amp;pages=696-704&amp;pmid=23263331&amp;doi=10.1093/cvr/cvs422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0024">
<span class="label">24.</span><cite>
Madhur M. S., Lob H. E., McCann L. A., et al., “Interleukin 17 Promotes Angiotensin II‐Induced Hypertension and Vascular Dysfunction,” Hypertension
55 (2010): 500–507, 10.1161/HYPERTENSIONAHA.109.145094.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.109.145094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2819301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20038749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Interleukin%2017%20Promotes%20Angiotensin%20II%E2%80%90Induced%20Hypertension%20and%20Vascular%20Dysfunction&amp;author=M.%20S.%20Madhur&amp;author=H.%20E.%20Lob&amp;author=L.%20A.%20McCann&amp;volume=55&amp;publication_year=2010&amp;pages=500-507&amp;pmid=20038749&amp;doi=10.1161/HYPERTENSIONAHA.109.145094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0025">
<span class="label">25.</span><cite>
Ye J., Ji Q., Liu J., et al., “Interleukin 22 Promotes Blood Pressure Elevation and Endothelial Dysfunction in Angiotensin II‐Treated Mice,” Journal of the American Heart Association
6, no. 10 (2017): e005875, 10.1161/JAHA.117.005875.
</cite> [<a href="https://doi.org/10.1161/JAHA.117.005875" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5721831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28974499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=Interleukin%2022%20Promotes%20Blood%20Pressure%20Elevation%20and%20Endothelial%20Dysfunction%20in%20Angiotensin%20II%E2%80%90Treated%20Mice&amp;author=J.%20Ye&amp;author=Q.%20Ji&amp;author=J.%20Liu&amp;volume=6&amp;issue=10&amp;publication_year=2017&amp;pages=e005875&amp;pmid=28974499&amp;doi=10.1161/JAHA.117.005875&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0026">
<span class="label">26.</span><cite>
Zemse S. M., Hilgers R. H., and Webb R. C., “Interleukin‐10 Counteracts Impaired Endothelium‐Dependent Relaxation Induced by ANG II in Murine Aortic Rings,” American Journal of Physiology. Heart and Circulatory Physiology
292 (2007): H3103–H3108, 10.1152/ajpheart.00456.2006.
</cite> [<a href="https://doi.org/10.1152/ajpheart.00456.2006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17322422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology.%20Heart%20and%20Circulatory%20Physiology&amp;title=Interleukin%E2%80%9010%20Counteracts%20Impaired%20Endothelium%E2%80%90Dependent%20Relaxation%20Induced%20by%20ANG%20II%20in%20Murine%20Aortic%20Rings&amp;author=S.%20M.%20Zemse&amp;author=R.%20H.%20Hilgers&amp;author=R.%20C.%20Webb&amp;volume=292&amp;publication_year=2007&amp;pages=H3103-H3108&amp;pmid=17322422&amp;doi=10.1152/ajpheart.00456.2006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0027">
<span class="label">27.</span><cite>
Didion S. P., Kinzenbaw D. A., Schrader L. I., Chu Y., and Faraci F. M., “Endogenous Interleukin‐10 Inhibits Angiotensin II‐Induced Vascular Dysfunction,” Hypertension
54 (2009): 619–624, 10.1161/HYPERTENSIONAHA.109.137158.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.109.137158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2861503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19620507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Endogenous%20Interleukin%E2%80%9010%20Inhibits%20Angiotensin%20II%E2%80%90Induced%20Vascular%20Dysfunction&amp;author=S.%20P.%20Didion&amp;author=D.%20A.%20Kinzenbaw&amp;author=L.%20I.%20Schrader&amp;author=Y.%20Chu&amp;author=F.%20M.%20Faraci&amp;volume=54&amp;publication_year=2009&amp;pages=619-624&amp;pmid=19620507&amp;doi=10.1161/HYPERTENSIONAHA.109.137158&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0028">
<span class="label">28.</span><cite>
Virdis A., Bacca A., Colucci R., et al., “Endothelial Dysfunction in Small Arteries of Essential Hypertensive Patients: Role of Cyclooxygenase‐2 in Oxidative Stress Generation,” Hypertension
62 (2013): 337–344, 10.1161/HYPERTENSIONAHA.111.00995.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.111.00995" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23734008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Endothelial%20Dysfunction%20in%20Small%20Arteries%20of%20Essential%20Hypertensive%20Patients:%20Role%20of%20Cyclooxygenase%E2%80%902%20in%20Oxidative%20Stress%20Generation&amp;author=A.%20Virdis&amp;author=A.%20Bacca&amp;author=R.%20Colucci&amp;volume=62&amp;publication_year=2013&amp;pages=337-344&amp;pmid=23734008&amp;doi=10.1161/HYPERTENSIONAHA.111.00995&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0029">
<span class="label">29.</span><cite>
Martínez‐Revelles S., Avendaño M. S., García‐Redondo A. B., et al., “Reciprocal Relationship Between Reactive Oxygen Species and Cyclooxygenase‐2 and Vascular Dysfunction in Hypertension,” Antioxidants &amp; Redox Signaling
18 (2013): 51–65, 10.1089/ars.2011.4335.
</cite> [<a href="https://doi.org/10.1089/ars.2011.4335" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22671943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxidants%20&amp;%20Redox%20Signaling&amp;title=Reciprocal%20Relationship%20Between%20Reactive%20Oxygen%20Species%20and%20Cyclooxygenase%E2%80%902%20and%20Vascular%20Dysfunction%20in%20Hypertension&amp;author=S.%20Mart%C3%ADnez%E2%80%90Revelles&amp;author=M.%20S.%20Avenda%C3%B1o&amp;author=A.%20B.%20Garc%C3%ADa%E2%80%90Redondo&amp;volume=18&amp;publication_year=2013&amp;pages=51-65&amp;pmid=22671943&amp;doi=10.1089/ars.2011.4335&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0030">
<span class="label">30.</span><cite>
Griendling K. K., Camargo L. L., Rios F. J., Alves‐Lopes R., Montezano A. C., and Touyz R. M., “Oxidative Stress and Hypertension,” Circulation Research
128 (2021): 993–1020, 10.1161/CIRCRESAHA.121.318063.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.121.318063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8293920/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33793335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Oxidative%20Stress%20and%20Hypertension&amp;author=K.%20K.%20Griendling&amp;author=L.%20L.%20Camargo&amp;author=F.%20J.%20Rios&amp;author=R.%20Alves%E2%80%90Lopes&amp;author=A.%20C.%20Montezano&amp;volume=128&amp;publication_year=2021&amp;pages=993-1020&amp;pmid=33793335&amp;doi=10.1161/CIRCRESAHA.121.318063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0031">
<span class="label">31.</span><cite>
Camargo L. L., Rios F. J., Montezano A. C., and Touyz R. M., “Reactive Oxygen Species in Hypertension,” Nature Reviews Cardiology
22 (2024): 20–37, 10.1038/s41569-024-01062-6.
</cite> [<a href="https://doi.org/10.1038/s41569-024-01062-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39048744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Cardiology&amp;title=Reactive%20Oxygen%20Species%20in%20Hypertension&amp;author=L.%20L.%20Camargo&amp;author=F.%20J.%20Rios&amp;author=A.%20C.%20Montezano&amp;author=R.%20M.%20Touyz&amp;volume=22&amp;publication_year=2024&amp;pages=20-37&amp;pmid=39048744&amp;doi=10.1038/s41569-024-01062-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0032">
<span class="label">32.</span><cite>
Dikalov S. I. and Dikalova A. E., “Contribution of Mitochondrial Oxidative Stress to Hypertension,” Current Opinion in Nephrology and Hypertension
25 (2016): 73–80, 10.1097/MNH.0000000000000198.
</cite> [<a href="https://doi.org/10.1097/MNH.0000000000000198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4766975/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26717313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Nephrology%20and%20Hypertension&amp;title=Contribution%20of%20Mitochondrial%20Oxidative%20Stress%20to%20Hypertension&amp;author=S.%20I.%20Dikalov&amp;author=A.%20E.%20Dikalova&amp;volume=25&amp;publication_year=2016&amp;pages=73-80&amp;pmid=26717313&amp;doi=10.1097/MNH.0000000000000198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0033">
<span class="label">33.</span><cite>
Wu Y., Ding Y., Ramprasath T., and Zou M. H., “Oxidative Stress, GTPCH1, and Endothelial Nitric Oxide Synthase Uncoupling in Hypertension,” Antioxidants &amp; Redox Signaling
34 (2021): 750–764, 10.1089/ars.2020.8112.
</cite> [<a href="https://doi.org/10.1089/ars.2020.8112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7910417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32363908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxidants%20&amp;%20Redox%20Signaling&amp;title=Oxidative%20Stress,%20GTPCH1,%20and%20Endothelial%20Nitric%20Oxide%20Synthase%20Uncoupling%20in%20Hypertension&amp;author=Y.%20Wu&amp;author=Y.%20Ding&amp;author=T.%20Ramprasath&amp;author=M.%20H.%20Zou&amp;volume=34&amp;publication_year=2021&amp;pages=750-764&amp;pmid=32363908&amp;doi=10.1089/ars.2020.8112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0034">
<span class="label">34.</span><cite>
Li H., Li Q., Zhang Y., et al., “Novel Treatment of Hypertension by Specifically Targeting E2F for Restoration of Endothelial Dihydrofolate Reductase and eNOS Function Under Oxidative Stress,” Hypertension
73 (2019): 179–189, 10.1161/HYPERTENSIONAHA.118.11643.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.118.11643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6310047/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30571557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Novel%20Treatment%20of%20Hypertension%20by%20Specifically%20Targeting%20E2F%20for%20Restoration%20of%20Endothelial%20Dihydrofolate%20Reductase%20and%20eNOS%20Function%20Under%20Oxidative%20Stress&amp;author=H.%20Li&amp;author=Q.%20Li&amp;author=Y.%20Zhang&amp;volume=73&amp;publication_year=2019&amp;pages=179-189&amp;pmid=30571557&amp;doi=10.1161/HYPERTENSIONAHA.118.11643&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0035">
<span class="label">35.</span><cite>
Hernanz R., Martín Á., Pérez‐Girón J. V., et al., “Pioglitazone Treatment Increases COX‐2‐Derived Prostacyclin Production and Reduces Oxidative Stress in Hypertensive Rats: Role in Vascular Function,” British Journal of Pharmacology
166 (2012): 1303–1319, 10.1111/j.1476-5381.2012.01825.x.
</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2012.01825.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3417448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22220498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Pioglitazone%20Treatment%20Increases%20COX%E2%80%902%E2%80%90Derived%20Prostacyclin%20Production%20and%20Reduces%20Oxidative%20Stress%20in%20Hypertensive%20Rats:%20Role%20in%20Vascular%20Function&amp;author=R.%20Hernanz&amp;author=%C3%81.%20Mart%C3%ADn&amp;author=J.%20V.%20P%C3%A9rez%E2%80%90Gir%C3%B3n&amp;volume=166&amp;publication_year=2012&amp;pages=1303-1319&amp;pmid=22220498&amp;doi=10.1111/j.1476-5381.2012.01825.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0036">
<span class="label">36.</span><cite>
Lopes R. A., Neves K. B., Tostes R. C., Montezano A. C., and Touyz R. M., “Downregulation of Nuclear Factor Erythroid 2‐Related Factor and Associated Antioxidant Genes Contributes to Redox‐Sensitive Vascular Dysfunction in Hypertension,” Hypertension
66 (2015): 1240–1250, 10.1161/HYPERTENSIONAHA.115.06163.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.115.06163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26503970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Downregulation%20of%20Nuclear%20Factor%20Erythroid%202%E2%80%90Related%20Factor%20and%20Associated%20Antioxidant%20Genes%20Contributes%20to%20Redox%E2%80%90Sensitive%20Vascular%20Dysfunction%20in%20Hypertension&amp;author=R.%20A.%20Lopes&amp;author=K.%20B.%20Neves&amp;author=R.%20C.%20Tostes&amp;author=A.%20C.%20Montezano&amp;author=R.%20M.%20Touyz&amp;volume=66&amp;publication_year=2015&amp;pages=1240-1250&amp;pmid=26503970&amp;doi=10.1161/HYPERTENSIONAHA.115.06163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0037">
<span class="label">37.</span><cite>
Dhyani N., Tian C., Gao L., Rudebush T. L., and Zucker I. H., “Nrf2‐Keap1 in Cardiovascular Disease: Which Is the Cart and Which the Horse?,” Physiology (Bethesda, Md.)
39 (2024): 288–301, 10.1152/physiol.00015.2024.</cite> [<a href="https://doi.org/10.1152/physiol.00015.2024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11460534/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38687468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiology%20(Bethesda,%20Md.)&amp;title=Nrf2%E2%80%90Keap1%20in%20Cardiovascular%20Disease:%20Which%20Is%20the%20Cart%20and%20Which%20the%20Horse?&amp;author=N.%20Dhyani&amp;author=C.%20Tian&amp;author=L.%20Gao&amp;author=T.%20L.%20Rudebush&amp;author=I.%20H.%20Zucker&amp;volume=39&amp;publication_year=2024&amp;pages=288-301&amp;pmid=38687468&amp;doi=10.1152/physiol.00015.2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0038">
<span class="label">38.</span><cite>
Daiber A. and Chlopicki S., “Revisiting Pharmacology of Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Evidence for Redox‐Based Therapies,” Free Radical Biology &amp; Medicine
157 (2020): 15–37, 10.1016/j.freeradbiomed.2020.02.026.
</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2020.02.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32131026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Free%20Radical%20Biology%20&amp;%20Medicine&amp;title=Revisiting%20Pharmacology%20of%20Oxidative%20Stress%20and%20Endothelial%20Dysfunction%20in%20Cardiovascular%20Disease:%20Evidence%20for%20Redox%E2%80%90Based%20Therapies&amp;author=A.%20Daiber&amp;author=S.%20Chlopicki&amp;volume=157&amp;publication_year=2020&amp;pages=15-37&amp;pmid=32131026&amp;doi=10.1016/j.freeradbiomed.2020.02.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0039">
<span class="label">39.</span><cite>
Alvarez Y., Pérez‐Girón J. V., Hernanz R., et al., “Losartan Reduces the Increased Participation of Cyclooxygenase‐2‐Derived Products in Vascular Responses of Hypertensive Rats,” Journal of Pharmacology and Experimental Therapeutics
321 (2007): 381–388, 10.1124/jpet.106.115287.
</cite> [<a href="https://doi.org/10.1124/jpet.106.115287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17244722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=Losartan%20Reduces%20the%20Increased%20Participation%20of%20Cyclooxygenase%E2%80%902%E2%80%90Derived%20Products%20in%20Vascular%20Responses%20of%20Hypertensive%20Rats&amp;author=Y.%20Alvarez&amp;author=J.%20V.%20P%C3%A9rez%E2%80%90Gir%C3%B3n&amp;author=R.%20Hernanz&amp;volume=321&amp;publication_year=2007&amp;pages=381-388&amp;pmid=17244722&amp;doi=10.1124/jpet.106.115287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0040">
<span class="label">40.</span><cite>
Alvarez Y., Briones A. M., Balfagón G., Alonso M. J., and Salaices M., “Hypertension Increases the Participation of Vasoconstrictor Prostanoids From Cyclooxygenase‐2 in Phenylephrine Responses,” Journal of Hypertension
23 (2005): 767–777, 10.1097/01.hjh.0000163145.12707.63.
</cite> [<a href="https://doi.org/10.1097/01.hjh.0000163145.12707.63" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15775781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hypertension&amp;title=Hypertension%20Increases%20the%20Participation%20of%20Vasoconstrictor%20Prostanoids%20From%20Cyclooxygenase%E2%80%902%20in%20Phenylephrine%20Responses&amp;author=Y.%20Alvarez&amp;author=A.%20M.%20Briones&amp;author=G.%20Balfag%C3%B3n&amp;author=M.%20J.%20Alonso&amp;author=M.%20Salaices&amp;volume=23&amp;publication_year=2005&amp;pages=767-777&amp;pmid=15775781&amp;doi=10.1097/01.hjh.0000163145.12707.63&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0041">
<span class="label">41.</span><cite>
Tian X. Y., Wong W. T., Leung F. P., et al., “Oxidative Stress‐Dependent Cyclooxygenase‐2‐Derived Prostaglandin f(2α) Impairs Endothelial Function in Renovascular Hypertensive Rats,” Antioxidants &amp; Redox Signaling
16 (2012): 363–373, 10.1089/ars.2010.3874.
</cite> [<a href="https://doi.org/10.1089/ars.2010.3874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3584508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21951274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxidants%20&amp;%20Redox%20Signaling&amp;title=Oxidative%20Stress%E2%80%90Dependent%20Cyclooxygenase%E2%80%902%E2%80%90Derived%20Prostaglandin%20f(2%CE%B1)%20Impairs%20Endothelial%20Function%20in%20Renovascular%20Hypertensive%20Rats&amp;author=X.%20Y.%20Tian&amp;author=W.%20T.%20Wong&amp;author=F.%20P.%20Leung&amp;volume=16&amp;publication_year=2012&amp;pages=363-373&amp;pmid=21951274&amp;doi=10.1089/ars.2010.3874&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0042">
<span class="label">42.</span><cite>
Ge J., Zhou Y., Li H., et al., “Prostacyclin Synthase Deficiency Leads to Exacerbation or Occurrence of Endothelium‐Dependent Contraction and Causes Cardiovascular Disorders Mainly via the Non‐TxA2 Prostanoids/TP Axis,” Circulation Research
135, no. 6 (2024): e133–e149, 10.1161/CIRCRESAHA.124.324924.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.124.324924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39082135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Prostacyclin%20Synthase%20Deficiency%20Leads%20to%20Exacerbation%20or%20Occurrence%20of%20Endothelium%E2%80%90Dependent%20Contraction%20and%20Causes%20Cardiovascular%20Disorders%20Mainly%20via%20the%20Non%E2%80%90TxA2%20Prostanoids/TP%20Axis&amp;author=J.%20Ge&amp;author=Y.%20Zhou&amp;author=H.%20Li&amp;volume=135&amp;issue=6&amp;publication_year=2024&amp;pages=e133-e149&amp;pmid=39082135&amp;doi=10.1161/CIRCRESAHA.124.324924&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0043">
<span class="label">43.</span><cite>
Hernanz R., Briones A. M., Salaices M., and Alonso M. J., “New Roles for old Pathways? A Circuitous Relationship Between Reactive Oxygen Species and Cyclo‐Oxygenase in Hypertension,” Clinical Science (London, England)
126 (2014): 111–121, 10.1042/CS20120651.</cite> [<a href="https://doi.org/10.1042/CS20120651" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24059588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Science%20(London,%20England)&amp;title=New%20Roles%20for%20old%20Pathways?%20A%20Circuitous%20Relationship%20Between%20Reactive%20Oxygen%20Species%20and%20Cyclo%E2%80%90Oxygenase%20in%20Hypertension&amp;author=R.%20Hernanz&amp;author=A.%20M.%20Briones&amp;author=M.%20Salaices&amp;author=M.%20J.%20Alonso&amp;volume=126&amp;publication_year=2014&amp;pages=111-121&amp;pmid=24059588&amp;doi=10.1042/CS20120651&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0044">
<span class="label">44.</span><cite>
Grosser T., Ricciotti E., and FitzGerald G. A., “The Cardiovascular Pharmacology of Nonsteroidal Anti‐Inflammatory Drugs,” Trends in Pharmacological Sciences
38, no. 8 (2017): 733–748, 10.1016/j.tips.2017.05.008.
</cite> [<a href="https://doi.org/10.1016/j.tips.2017.05.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5676556/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28651847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Pharmacological%20Sciences&amp;title=The%20Cardiovascular%20Pharmacology%20of%20Nonsteroidal%20Anti%E2%80%90Inflammatory%20Drugs&amp;author=T.%20Grosser&amp;author=E.%20Ricciotti&amp;author=G.%20A.%20FitzGerald&amp;volume=38&amp;issue=8&amp;publication_year=2017&amp;pages=733-748&amp;pmid=28651847&amp;doi=10.1016/j.tips.2017.05.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0045">
<span class="label">45.</span><cite>
Avendaño M. S., Martínez‐Revelles S., Aguado A., et al., “Role of COX‐2‐Derived PGE2 on Vascular Stiffness and Function in Hypertension,” British Journal of Pharmacology
173, no. 9 (2016): 1541–1555, 10.1111/bph.13457.
</cite> [<a href="https://doi.org/10.1111/bph.13457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4831311/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26856544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Role%20of%20COX%E2%80%902%E2%80%90Derived%20PGE2%20on%20Vascular%20Stiffness%20and%20Function%20in%20Hypertension&amp;author=M.%20S.%20Avenda%C3%B1o&amp;author=S.%20Mart%C3%ADnez%E2%80%90Revelles&amp;author=A.%20Aguado&amp;volume=173&amp;issue=9&amp;publication_year=2016&amp;pages=1541-1555&amp;pmid=26856544&amp;doi=10.1111/bph.13457&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0046">
<span class="label">46.</span><cite>
Avendaño M. S., García‐Redondo A. B., Zalba G., et al., “mPGES‐1 (Microsomal Prostaglandin E Synthase‐1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress,” Hypertension
72 (2018): 492–502, 10.1161/HYPERTENSIONAHA.118.10833.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.118.10833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29891646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=mPGES%E2%80%901%20(Microsomal%20Prostaglandin%20E%20Synthase%E2%80%901)%20Mediates%20Vascular%20Dysfunction%20in%20Hypertension%20Through%20Oxidative%20Stress&amp;author=M.%20S.%20Avenda%C3%B1o&amp;author=A.%20B.%20Garc%C3%ADa%E2%80%90Redondo&amp;author=G.%20Zalba&amp;volume=72&amp;publication_year=2018&amp;pages=492-502&amp;pmid=29891646&amp;doi=10.1161/HYPERTENSIONAHA.118.10833&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0047">
<span class="label">47.</span><cite>
Serhan C. N. and Levy B. D., “Resolvins in Inflammation: Emergence of the Pro‐Resolving Superfamily of Mediators,” Journal of Clinical Investigation
128, no. 7 (2018): 2657–2669, 10.1172/JCI97943.
</cite> [<a href="https://doi.org/10.1172/JCI97943" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6025982/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29757195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Resolvins%20in%20Inflammation:%20Emergence%20of%20the%20Pro%E2%80%90Resolving%20Superfamily%20of%20Mediators&amp;author=C.%20N.%20Serhan&amp;author=B.%20D.%20Levy&amp;volume=128&amp;issue=7&amp;publication_year=2018&amp;pages=2657-2669&amp;pmid=29757195&amp;doi=10.1172/JCI97943&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0048">
<span class="label">48.</span><cite>
Dalli J. and Serhan C. N., “Identification and Structure Elucidation of the Pro‐Resolving Mediators Provides Novel Leads for Resolution Pharmacology,” British Journal of Pharmacology
176, no. 8 (2019): 1024–1037, 10.1111/bph.14336.
</cite> [<a href="https://doi.org/10.1111/bph.14336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6451074/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29679485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Identification%20and%20Structure%20Elucidation%20of%20the%20Pro%E2%80%90Resolving%20Mediators%20Provides%20Novel%20Leads%20for%20Resolution%20Pharmacology&amp;author=J.%20Dalli&amp;author=C.%20N.%20Serhan&amp;volume=176&amp;issue=8&amp;publication_year=2019&amp;pages=1024-1037&amp;pmid=29679485&amp;doi=10.1111/bph.14336&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0049">
<span class="label">49.</span><cite>
Fredman G. and Serhan C. N., “Specialized Pro‐Resolving Mediators in Vascular Inflammation and Atherosclerotic Cardiovascular Disease,” Nature Reviews. Cardiology
21, no. 11 (2024): 808–823, 10.1038/s41569-023-00984-x.
</cite> [<a href="https://doi.org/10.1038/s41569-023-00984-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38216693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Cardiology&amp;title=Specialized%20Pro%E2%80%90Resolving%20Mediators%20in%20Vascular%20Inflammation%20and%20Atherosclerotic%20Cardiovascular%20Disease&amp;author=G.%20Fredman&amp;author=C.%20N.%20Serhan&amp;volume=21&amp;issue=11&amp;publication_year=2024&amp;pages=808-823&amp;pmid=38216693&amp;doi=10.1038/s41569-023-00984-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0050">
<span class="label">50.</span><cite>
Serhan C. N., “Pro‐Resolving Lipid Mediators Are Leads for Resolution Physiology,” Nature
510, no. 7503 (2014): 92–101, 10.1038/nature13479.
</cite> [<a href="https://doi.org/10.1038/nature13479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4263681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24899309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Pro%E2%80%90Resolving%20Lipid%20Mediators%20Are%20Leads%20for%20Resolution%20Physiology&amp;author=C.%20N.%20Serhan&amp;volume=510&amp;issue=7503&amp;publication_year=2014&amp;pages=92-101&amp;pmid=24899309&amp;doi=10.1038/nature13479&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0051">
<span class="label">51.</span><cite>
Dalli J., Chiang N., and Serhan C. N., “Elucidation of Novel 13‐Series Resolvins That Increase With Atorvastatin and Clear Infections,” Nature Medicine
21, no. 9 (2015): 1071–1075, 10.1038/nm.3911.</cite> [<a href="https://doi.org/10.1038/nm.3911" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4560998/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26236990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Medicine&amp;title=Elucidation%20of%20Novel%2013%E2%80%90Series%20Resolvins%20That%20Increase%20With%20Atorvastatin%20and%20Clear%20Infections&amp;author=J.%20Dalli&amp;author=N.%20Chiang&amp;author=C.%20N.%20Serhan&amp;volume=21&amp;issue=9&amp;publication_year=2015&amp;pages=1071-1075&amp;pmid=26236990&amp;doi=10.1038/nm.3911&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0052">
<span class="label">52.</span><cite>
Díaz Del Campo L. S., Rodrigues‐Díez R., Salaices M., Briones A. M., and García‐Redondo A. B., “Specialized Pro‐Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling,” International Journal of Molecular Sciences
23, no. 7 (2022): 3592, 10.3390/ijms23073592.
</cite> [<a href="https://doi.org/10.3390/ijms23073592" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8998739/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35408952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Specialized%20Pro%E2%80%90Resolving%20Lipid%20Mediators:%20New%20Therapeutic%20Approaches%20for%20Vascular%20Remodeling&amp;author=L.%20S.%20D%C3%ADaz%20Del%20Campo&amp;author=R.%20Rodrigues%E2%80%90D%C3%ADez&amp;author=M.%20Salaices&amp;author=A.%20M.%20Briones&amp;author=A.%20B.%20Garc%C3%ADa%E2%80%90Redondo&amp;volume=23&amp;issue=7&amp;publication_year=2022&amp;pages=3592&amp;pmid=35408952&amp;doi=10.3390/ijms23073592&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0053">
<span class="label">53.</span><cite>
Spite M. and Fredman G., “Insights Into the Role of the Resolvin D2‐GPR18 Signaling Axis in Cardiovascular Physiology and Disease,” Advances in Pharmacology
97 (2023): 257–281, 10.1016/bs.apha.2022.12.005.
</cite> [<a href="https://doi.org/10.1016/bs.apha.2022.12.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37236761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20Pharmacology&amp;title=Insights%20Into%20the%20Role%20of%20the%20Resolvin%20D2%E2%80%90GPR18%20Signaling%20Axis%20in%20Cardiovascular%20Physiology%20and%20Disease&amp;author=M.%20Spite&amp;author=G.%20Fredman&amp;volume=97&amp;publication_year=2023&amp;pages=257-281&amp;pmid=37236761&amp;doi=10.1016/bs.apha.2022.12.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0054">
<span class="label">54.</span><cite>
Conte M. S., Desai T. A., Wu B., Schaller M., and Werlin E., “Pro‐Resolving Lipid Mediators in Vascular Disease,” Journal of Clinical Investigation
128, no. 9 (2018): 3727–3735, 10.1172/JCI97947.
</cite> [<a href="https://doi.org/10.1172/JCI97947" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6118638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30168805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Pro%E2%80%90Resolving%20Lipid%20Mediators%20in%20Vascular%20Disease&amp;author=M.%20S.%20Conte&amp;author=T.%20A.%20Desai&amp;author=B.%20Wu&amp;author=M.%20Schaller&amp;author=E.%20Werlin&amp;volume=128&amp;issue=9&amp;publication_year=2018&amp;pages=3727-3735&amp;pmid=30168805&amp;doi=10.1172/JCI97947&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0055">
<span class="label">55.</span><cite>
Fredman G., Hellmann J., Proto J. D., et al., “An Imbalance Between Specialized Pro‐Resolving Lipid Mediators and Pro‐Inflammatory Leukotrienes Promotes Instability of Atherosclerotic Plaques,” Nature Communications
7 (2016): 12859, 10.1038/ncomms12859.</cite> [<a href="https://doi.org/10.1038/ncomms12859" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5036151/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27659679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=An%20Imbalance%20Between%20Specialized%20Pro%E2%80%90Resolving%20Lipid%20Mediators%20and%20Pro%E2%80%90Inflammatory%20Leukotrienes%20Promotes%20Instability%20of%20Atherosclerotic%20Plaques&amp;author=G.%20Fredman&amp;author=J.%20Hellmann&amp;author=J.%20D.%20Proto&amp;volume=7&amp;publication_year=2016&amp;pages=12859&amp;pmid=27659679&amp;doi=10.1038/ncomms12859&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0056">
<span class="label">56.</span><cite>
Petri M. H., Thul S., Andonova T., et al., “Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms,” JACC: Basic to Translational Science
3, no. 6 (2018): 719–727, 10.1016/j.jacbts.2018.08.005.
</cite> [<a href="https://doi.org/10.1016/j.jacbts.2018.08.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6314955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30623131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC:%20Basic%20to%20Translational%20Science&amp;title=Resolution%20of%20Inflammation%20Through%20the%20Lipoxin%20and%20ALX/FPR2%20Receptor%20Pathway%20Protects%20Against%20Abdominal%20Aortic%20Aneurysms&amp;author=M.%20H.%20Petri&amp;author=S.%20Thul&amp;author=T.%20Andonova&amp;volume=3&amp;issue=6&amp;publication_year=2018&amp;pages=719-727&amp;pmid=30623131&amp;doi=10.1016/j.jacbts.2018.08.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0057">
<span class="label">57.</span><cite>
Arnardottir H., Thul S., Pawelzik S. C., et al., “The Resolvin D1 Receptor GPR32 Transduces Inflammation Resolution and Atheroprotection,” Journal of Clinical Investigation
131, no. 24 (2021): e142883, 10.1172/JCI142883.
</cite> [<a href="https://doi.org/10.1172/JCI142883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8670838/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34699386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=The%20Resolvin%20D1%20Receptor%20GPR32%20Transduces%20Inflammation%20Resolution%20and%20Atheroprotection&amp;author=H.%20Arnardottir&amp;author=S.%20Thul&amp;author=S.%20C.%20Pawelzik&amp;volume=131&amp;issue=24&amp;publication_year=2021&amp;pages=e142883&amp;pmid=34699386&amp;doi=10.1172/JCI142883&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0058">
<span class="label">58.</span><cite>
Bardin M., Pawelzik S. C., Lagrange J., et al., “The Resolvin D2‐GPR18 Axis Is Expressed in Human Coronary Atherosclerosis and Transduces Atheroprotection in Apolipoprotein E Deficient Mice,” Biochemical Pharmacology
201 (2022): 115075, 10.1016/j.bcp.2022.115075.
</cite> [<a href="https://doi.org/10.1016/j.bcp.2022.115075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35525326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20Pharmacology&amp;title=The%20Resolvin%20D2%E2%80%90GPR18%20Axis%20Is%20Expressed%20in%20Human%20Coronary%20Atherosclerosis%20and%20Transduces%20Atheroprotection%20in%20Apolipoprotein%20E%20Deficient%20Mice&amp;author=M.%20Bardin&amp;author=S.%20C.%20Pawelzik&amp;author=J.%20Lagrange&amp;volume=201&amp;publication_year=2022&amp;pages=115075&amp;pmid=35525326&amp;doi=10.1016/j.bcp.2022.115075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0059">
<span class="label">59.</span><cite>
Rodrigues‐Diez R., Ballesteros‐Martinez C., Moreno‐Carriles R. M., et al., “Resolvin D2 Prevents Vascular Remodeling, Hypercontractility and Endothelial Dysfunction in Obese Hypertensive Mice Through Modulation of Vascular and Proinflammatory Factors,” Biomedicine &amp; Pharmacotherapy
174 (2024): 116564, 10.1016/j.biopha.2024.116564.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2024.116564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38608525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=Resolvin%20D2%20Prevents%20Vascular%20Remodeling,%20Hypercontractility%20and%20Endothelial%20Dysfunction%20in%20Obese%20Hypertensive%20Mice%20Through%20Modulation%20of%20Vascular%20and%20Proinflammatory%20Factors&amp;author=R.%20Rodrigues%E2%80%90Diez&amp;author=C.%20Ballesteros%E2%80%90Martinez&amp;author=R.%20M.%20Moreno%E2%80%90Carriles&amp;volume=174&amp;publication_year=2024&amp;pages=116564&amp;pmid=38608525&amp;doi=10.1016/j.biopha.2024.116564&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0060">
<span class="label">60.</span><cite>
Sansbury B. E. and Spite M., “Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology,” Circulation Research
119, no. 1 (2016): 113–130, 10.1161/CIRCRESAHA.116.307308.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.116.307308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5260827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27340271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Resolution%20of%20Acute%20Inflammation%20and%20the%20Role%20of%20Resolvins%20in%20Immunity,%20Thrombosis,%20and%20Vascular%20Biology&amp;author=B.%20E.%20Sansbury&amp;author=M.%20Spite&amp;volume=119&amp;issue=1&amp;publication_year=2016&amp;pages=113-130&amp;pmid=27340271&amp;doi=10.1161/CIRCRESAHA.116.307308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0061">
<span class="label">61.</span><cite>
Zhang J., Liu S., Ding W., Wan J., Qin J. J., and Wang M., “Resolution of Inflammation, an Active Process to Restore the Immune Microenvironment Balance: A Novel Drug Target for Treating Arterial Hypertension,” Ageing Research Reviews
99 (2024): 102352, 10.1016/j.arr.2024.102352.
</cite> [<a href="https://doi.org/10.1016/j.arr.2024.102352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38857706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ageing%20Research%20Reviews&amp;title=Resolution%20of%20Inflammation,%20an%20Active%20Process%20to%20Restore%20the%20Immune%20Microenvironment%20Balance:%20A%20Novel%20Drug%20Target%20for%20Treating%20Arterial%20Hypertension&amp;author=J.%20Zhang&amp;author=S.%20Liu&amp;author=W.%20Ding&amp;author=J.%20Wan&amp;author=J.%20J.%20Qin&amp;volume=99&amp;publication_year=2024&amp;pages=102352&amp;pmid=38857706&amp;doi=10.1016/j.arr.2024.102352&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0062">
<span class="label">62.</span><cite>
Bäck M., “Icosapent Ethyl in Cardiovascular Prevention: Resolution of Inflammation Through the Eicosapentaenoic Acid‐Resolvin E1‐ChemR23 Axis,” Pharmacology &amp; Therapeutics
247 (2023): 108439, 10.1016/j.pharmthera.2023.108439.
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2023.108439" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37201735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20&amp;%20Therapeutics&amp;title=Icosapent%20Ethyl%20in%20Cardiovascular%20Prevention:%20Resolution%20of%20Inflammation%20Through%20the%20Eicosapentaenoic%20Acid%E2%80%90Resolvin%20E1%E2%80%90ChemR23%20Axis&amp;author=M.%20B%C3%A4ck&amp;volume=247&amp;publication_year=2023&amp;pages=108439&amp;pmid=37201735&amp;doi=10.1016/j.pharmthera.2023.108439&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0063">
<span class="label">63.</span><cite>
Spite M., Norling L. V., Summers L., et al., “Resolvin D2 Is a Potent Regulator of Leukocytes and Controls Microbial Sepsis,” Nature
461, no. 7268 (2009): 1287–1291, 10.1038/nature08541.
</cite> [<a href="https://doi.org/10.1038/nature08541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2779525/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19865173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Resolvin%20D2%20Is%20a%20Potent%20Regulator%20of%20Leukocytes%20and%20Controls%20Microbial%20Sepsis&amp;author=M.%20Spite&amp;author=L.%20V.%20Norling&amp;author=L.%20Summers&amp;volume=461&amp;issue=7268&amp;publication_year=2009&amp;pages=1287-1291&amp;pmid=19865173&amp;doi=10.1038/nature08541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0064">
<span class="label">64.</span><cite>
Maekawa T., Hosur K., Abe T., et al., “Antagonistic Effects of IL‐17 and D‐Resolvins on Endothelial Del‐1 Expression Through a GSK‐3β‐C/EBPβ Pathway,” Nature Communications
6 (2015): 8272, 10.1038/ncomms9272.</cite> [<a href="https://doi.org/10.1038/ncomms9272" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4573473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26374165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Antagonistic%20Effects%20of%20IL%E2%80%9017%20and%20D%E2%80%90Resolvins%20on%20Endothelial%20Del%E2%80%901%20Expression%20Through%20a%20GSK%E2%80%903%CE%B2%E2%80%90C/EBP%CE%B2%20Pathway&amp;author=T.%20Maekawa&amp;author=K.%20Hosur&amp;author=T.%20Abe&amp;volume=6&amp;publication_year=2015&amp;pages=8272&amp;pmid=26374165&amp;doi=10.1038/ncomms9272&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0065">
<span class="label">65.</span><cite>
Jannaway M., Torrens C., Warner J. A., and Sampson A. P., “Resolvin E1, Resolvin D1 and Resolvin D2 Inhibit Constriction of Rat Thoracic Aorta and Human Pulmonary Artery Induced by the Thromboxane Mimetic U46619,” British Journal of Pharmacology
175, no. 7 (2018): 1100–1108, 10.1111/bph.14151.
</cite> [<a href="https://doi.org/10.1111/bph.14151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5843708/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29352769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Resolvin%20E1,%20Resolvin%20D1%20and%20Resolvin%20D2%20Inhibit%20Constriction%20of%20Rat%20Thoracic%20Aorta%20and%20Human%20Pulmonary%20Artery%20Induced%20by%20the%20Thromboxane%20Mimetic%20U46619&amp;author=M.%20Jannaway&amp;author=C.%20Torrens&amp;author=J.%20A.%20Warner&amp;author=A.%20P.%20Sampson&amp;volume=175&amp;issue=7&amp;publication_year=2018&amp;pages=1100-1108&amp;pmid=29352769&amp;doi=10.1111/bph.14151&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0066">
<span class="label">66.</span><cite>
Celik Z., Ozen G., Sunar S., et al., “Effect of Specialized Pro‐Resolving Lipid Mediators in the Regulation of Vascular Tone and Inflammation in Human Saphenous Vein,” Prostaglandins &amp; Other Lipid Mediators
169 (2023): 106786, 10.1016/j.prostaglandins.2023.106786.
</cite> [<a href="https://doi.org/10.1016/j.prostaglandins.2023.106786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37806440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins%20&amp;%20Other%20Lipid%20Mediators&amp;title=Effect%20of%20Specialized%20Pro%E2%80%90Resolving%20Lipid%20Mediators%20in%20the%20Regulation%20of%20Vascular%20Tone%20and%20Inflammation%20in%20Human%20Saphenous%20Vein&amp;author=Z.%20Celik&amp;author=G.%20Ozen&amp;author=S.%20Sunar&amp;volume=169&amp;publication_year=2023&amp;pages=106786&amp;pmid=37806440&amp;doi=10.1016/j.prostaglandins.2023.106786&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0067">
<span class="label">67.</span><cite>
Díaz Del Campo L. S., García‐Redondo A. B., Rodríguez C., et al., “Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II‐Induced Hypertension,” Hypertension
80, no. 1 (2023): 84–96, 10.1161/HYPERTENSIONAHA.122.19448.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.122.19448" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36337053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Resolvin%20D2%20Attenuates%20Cardiovascular%20Damage%20in%20Angiotensin%20II%E2%80%90Induced%20Hypertension&amp;author=L.%20S.%20D%C3%ADaz%20Del%20Campo&amp;author=A.%20B.%20Garc%C3%ADa%E2%80%90Redondo&amp;author=C.%20Rodr%C3%ADguez&amp;volume=80&amp;issue=1&amp;publication_year=2023&amp;pages=84-96&amp;pmid=36337053&amp;doi=10.1161/HYPERTENSIONAHA.122.19448&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0068">
<span class="label">68.</span><cite>
Edwards‐Glenn J. M., Fontes M. T., Waigi E. W., et al., “Specialized Pro‐Resolving Mediator Improves Vascular Relaxation via Formyl Peptide Receptor‐2,” American Journal of Hypertension
36, no. 10 (2023): 542–550, 10.1093/ajh/hpad062.
</cite> [<a href="https://doi.org/10.1093/ajh/hpad062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10502783/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37439351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Hypertension&amp;title=Specialized%20Pro%E2%80%90Resolving%20Mediator%20Improves%20Vascular%20Relaxation%20via%20Formyl%20Peptide%20Receptor%E2%80%902&amp;author=J.%20M.%20Edwards%E2%80%90Glenn&amp;author=M.%20T.%20Fontes&amp;author=E.%20W.%20Waigi&amp;volume=36&amp;issue=10&amp;publication_year=2023&amp;pages=542-550&amp;pmid=37439351&amp;doi=10.1093/ajh/hpad062&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0069">
<span class="label">69.</span><cite>
Zhang J., Yin Z., Xu Y., et al., “Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II‐Induced Hypertensive Mice,” Hypertension
80, no. 12 (2023): 2650–2664, 10.1161/HYPERTENSIONAHA.123.21348.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.123.21348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37800344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Resolvin%20E1/ChemR23%20Protects%20Against%20Hypertension%20and%20Vascular%20Remodeling%20in%20Angiotensin%20II%E2%80%90Induced%20Hypertensive%20Mice&amp;author=J.%20Zhang&amp;author=Z.%20Yin&amp;author=Y.%20Xu&amp;volume=80&amp;issue=12&amp;publication_year=2023&amp;pages=2650-2664&amp;pmid=37800344&amp;doi=10.1161/HYPERTENSIONAHA.123.21348&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0070">
<span class="label">70.</span><cite>
Wei C., Zhang J., Peng S., et al., “Resolvin D1 Attenuates Ang II‐Induced Hypertension in Mice by Inhibiting the Proliferation, Migration and Phenotypic Transformation of Vascular Smooth Muscle Cells by Blocking the RhoA/Mitogen‐Activated Protein Kinase Pathway,” Journal of Hypertension
42, no. 3 (2024): 420–431, 10.1097/HJH.0000000000003610.
</cite> [<a href="https://doi.org/10.1097/HJH.0000000000003610" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10842678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37937508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hypertension&amp;title=Resolvin%20D1%20Attenuates%20Ang%20II%E2%80%90Induced%20Hypertension%20in%20Mice%20by%20Inhibiting%20the%20Proliferation,%20Migration%20and%20Phenotypic%20Transformation%20of%20Vascular%20Smooth%20Muscle%20Cells%20by%20Blocking%20the%20RhoA/Mitogen%E2%80%90Activated%20Protein%20Kinase%20Pathway&amp;author=C.%20Wei&amp;author=J.%20Zhang&amp;author=S.%20Peng&amp;volume=42&amp;issue=3&amp;publication_year=2024&amp;pages=420-431&amp;pmid=37937508&amp;doi=10.1097/HJH.0000000000003610&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0071">
<span class="label">71.</span><cite>
Bennett M. R., Sinha S., and Owens G. K., “Vascular Smooth Muscle Cells in Atherosclerosis,” Circulation Research
118, no. 4 (2016): 692–702, 10.1161/CIRCRESAHA.115.306361.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.115.306361" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4762053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26892967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Vascular%20Smooth%20Muscle%20Cells%20in%20Atherosclerosis&amp;author=M.%20R.%20Bennett&amp;author=S.%20Sinha&amp;author=G.%20K.%20Owens&amp;volume=118&amp;issue=4&amp;publication_year=2016&amp;pages=692-702&amp;pmid=26892967&amp;doi=10.1161/CIRCRESAHA.115.306361&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0072">
<span class="label">72.</span><cite>
Salic K., Morrison M. C., Verschuren L., et al., “Resolvin E1 Attenuates Atherosclerosis in Absence of Cholesterol‐Lowering Effects and on Top of Atorvastatin,” Atherosclerosis
250 (2016): 158–165, 10.1016/j.atherosclerosis.2016.05.001.
</cite> [<a href="https://doi.org/10.1016/j.atherosclerosis.2016.05.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27236706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Resolvin%20E1%20Attenuates%20Atherosclerosis%20in%20Absence%20of%20Cholesterol%E2%80%90Lowering%20Effects%20and%20on%20Top%20of%20Atorvastatin&amp;author=K.%20Salic&amp;author=M.%20C.%20Morrison&amp;author=L.%20Verschuren&amp;volume=250&amp;publication_year=2016&amp;pages=158-165&amp;pmid=27236706&amp;doi=10.1016/j.atherosclerosis.2016.05.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0073">
<span class="label">73.</span><cite>
Petri M. H., Laguna‐Fernandez A., Arnardottir H., et al., “Aspirin‐Triggered Lipoxin A4 Inhibits Atherosclerosis Progression in Apolipoprotein E−/− Mice,” British Journal of Pharmacology
174, no. 22 (2017): 4043–4054, 10.1111/bph.13707.
</cite> [<a href="https://doi.org/10.1111/bph.13707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5659998/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28071789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Aspirin%E2%80%90Triggered%20Lipoxin%20A4%20Inhibits%20Atherosclerosis%20Progression%20in%20Apolipoprotein%20E%E2%88%92/%E2%88%92%20Mice&amp;author=M.%20H.%20Petri&amp;author=A.%20Laguna%E2%80%90Fernandez&amp;author=H.%20Arnardottir&amp;volume=174&amp;issue=22&amp;publication_year=2017&amp;pages=4043-4054&amp;pmid=28071789&amp;doi=10.1111/bph.13707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0074">
<span class="label">74.</span><cite>
Brennan E. P., Mohan M., McClelland A., et al., “Lipoxins Protect Against Inflammation in Diabetes‐Associated Atherosclerosis,” Diabetes
67, no. 12 (2018): 2657–2667, 10.2337/db17-1317.
</cite> [<a href="https://doi.org/10.2337/db17-1317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30213823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Lipoxins%20Protect%20Against%20Inflammation%20in%20Diabetes%E2%80%90Associated%20Atherosclerosis&amp;author=E.%20P.%20Brennan&amp;author=M.%20Mohan&amp;author=A.%20McClelland&amp;volume=67&amp;issue=12&amp;publication_year=2018&amp;pages=2657-2667&amp;pmid=30213823&amp;doi=10.2337/db17-1317&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0075">
<span class="label">75.</span><cite>
Viola J. R., Lemnitzer P., Jansen Y., et al., “Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice,” Circulation Research
119, no. 9 (2016): 1030–1038, 10.1161/CIRCRESAHA.116.309492.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.116.309492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27531933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Resolving%20Lipid%20Mediators%20Maresin%201%20and%20Resolvin%20D2%20Prevent%20Atheroprogression%20in%20Mice&amp;author=J.%20R.%20Viola&amp;author=P.%20Lemnitzer&amp;author=Y.%20Jansen&amp;volume=119&amp;issue=9&amp;publication_year=2016&amp;pages=1030-1038&amp;pmid=27531933&amp;doi=10.1161/CIRCRESAHA.116.309492&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0076">
<span class="label">76.</span><cite>
Laguna‐Fernandez A., Checa A., Carracedo M., et al., “ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low‐Density Lipoprotein Uptake and Phagocytosis in Macrophages,” Circulation
138, no. 16 (2018): 1693–1705, 10.1161/CIRCULATIONAHA.117.032801.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.117.032801" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6200387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29739755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=ERV1/ChemR23%20Signaling%20Protects%20Against%20Atherosclerosis%20by%20Modifying%20Oxidized%20Low%E2%80%90Density%20Lipoprotein%20Uptake%20and%20Phagocytosis%20in%20Macrophages&amp;author=A.%20Laguna%E2%80%90Fernandez&amp;author=A.%20Checa&amp;author=M.%20Carracedo&amp;volume=138&amp;issue=16&amp;publication_year=2018&amp;pages=1693-1705&amp;pmid=29739755&amp;doi=10.1161/CIRCULATIONAHA.117.032801&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0077">
<span class="label">77.</span><cite>
Lipscomb M., Walis S., Marinello M., et al., “Resolvin D2 Limits Atherosclerosis Progression via Myeloid Cell‐GPR18,” FASEB Journal
38, no. 6 (2024): e23555, 10.1096/fj.202302336RR.
</cite> [<a href="https://doi.org/10.1096/fj.202302336RR" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38498346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20Journal&amp;title=Resolvin%20D2%20Limits%20Atherosclerosis%20Progression%20via%20Myeloid%20Cell%E2%80%90GPR18&amp;author=M.%20Lipscomb&amp;author=S.%20Walis&amp;author=M.%20Marinello&amp;volume=38&amp;issue=6&amp;publication_year=2024&amp;pages=e23555&amp;pmid=38498346&amp;doi=10.1096/fj.202302336RR&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0078">
<span class="label">78.</span><cite>
Walker M. E., De Matteis R., Perretti M., and Dalli J., “Resolvin T4 Enhances Macrophage Cholesterol Efflux to Reduce Vascular Disease,” Nature Communications
15, no. 1 (2024): 975, 10.1038/s41467-024-44868-1.</cite> [<a href="https://doi.org/10.1038/s41467-024-44868-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10844649/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38316794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Resolvin%20T4%20Enhances%20Macrophage%20Cholesterol%20Efflux%20to%20Reduce%20Vascular%20Disease&amp;author=M.%20E.%20Walker&amp;author=R.%20De%20Matteis&amp;author=M.%20Perretti&amp;author=J.%20Dalli&amp;volume=15&amp;issue=1&amp;publication_year=2024&amp;pages=975&amp;pmid=38316794&amp;doi=10.1038/s41467-024-44868-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0079">
<span class="label">79.</span><cite>
Puertas‐Umbert L., Almendra‐Pegueros R., Jiménez‐Altayó F., et al., “Novel Pharmacological Approaches in Abdominal Aortic Aneurysm,” Clinical Science (London, England)
137, no. 15 (2023): 1167–1194, 10.1042/CS20220795.</cite> [<a href="https://doi.org/10.1042/CS20220795" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10415166/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37559446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Science%20(London,%20England)&amp;title=Novel%20Pharmacological%20Approaches%20in%20Abdominal%20Aortic%20Aneurysm&amp;author=L.%20Puertas%E2%80%90Umbert&amp;author=R.%20Almendra%E2%80%90Pegueros&amp;author=F.%20Jim%C3%A9nez%E2%80%90Altay%C3%B3&amp;volume=137&amp;issue=15&amp;publication_year=2023&amp;pages=1167-1194&amp;pmid=37559446&amp;doi=10.1042/CS20220795&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0080">
<span class="label">80.</span><cite>
Medina F., de Haro J., Florez A., and Acin F., “Relationship Between Endothelial Dependent Vasodilation and Size of Abdominal Aortic Aneurysms,” Annals of Vascular Surgery
24, no. 6 (2010): 752–757, 10.1016/j.avsg.2009.11.011.
</cite> [<a href="https://doi.org/10.1016/j.avsg.2009.11.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20638617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Vascular%20Surgery&amp;title=Relationship%20Between%20Endothelial%20Dependent%20Vasodilation%20and%20Size%20of%20Abdominal%20Aortic%20Aneurysms&amp;author=F.%20Medina&amp;author=J.%20de%20Haro&amp;author=A.%20Florez&amp;author=F.%20Acin&amp;volume=24&amp;issue=6&amp;publication_year=2010&amp;pages=752-757&amp;pmid=20638617&amp;doi=10.1016/j.avsg.2009.11.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0081">
<span class="label">81.</span><cite>
Lee R., Bellamkonda K., Jones A., et al., “Flow Mediated Dilatation and Progression of Abdominal Aortic Aneurysms,” European Journal of Vascular and Endovascular Surgery
53, no. 6 (2017): 820–829, 10.1016/j.ejvs.2017.03.001.
</cite> [<a href="https://doi.org/10.1016/j.ejvs.2017.03.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5496669/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28416190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Vascular%20and%20Endovascular%20Surgery&amp;title=Flow%20Mediated%20Dilatation%20and%20Progression%20of%20Abdominal%20Aortic%20Aneurysms&amp;author=R.%20Lee&amp;author=K.%20Bellamkonda&amp;author=A.%20Jones&amp;volume=53&amp;issue=6&amp;publication_year=2017&amp;pages=820-829&amp;pmid=28416190&amp;doi=10.1016/j.ejvs.2017.03.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0082">
<span class="label">82.</span><cite>
Siu K. L., Li Q., Zhang Y., et al., “NOX Isoforms in the Development of Abdominal Aortic Aneurysm,” Redox Biology
11 (2017): 118–125, 10.1016/j.redox.2016.11.002.
</cite> [<a href="https://doi.org/10.1016/j.redox.2016.11.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5133668/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27912196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Redox%20Biology&amp;title=NOX%20Isoforms%20in%20the%20Development%20of%20Abdominal%20Aortic%20Aneurysm&amp;author=K.%20L.%20Siu&amp;author=Q.%20Li&amp;author=Y.%20Zhang&amp;volume=11&amp;publication_year=2017&amp;pages=118-125&amp;pmid=27912196&amp;doi=10.1016/j.redox.2016.11.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0083">
<span class="label">83.</span><cite>
Wu J., Shyy M., Shyy J. Y., and Xiao H., “Role of Inflammasomes in Endothelial Dysfunction,” British Journal of Pharmacology
181 (2024): 4958–4972, 10.1111/bph.16479.
</cite> [<a href="https://doi.org/10.1111/bph.16479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38952037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Role%20of%20Inflammasomes%20in%20Endothelial%20Dysfunction&amp;author=J.%20Wu&amp;author=M.%20Shyy&amp;author=J.%20Y.%20Shyy&amp;author=H.%20Xiao&amp;volume=181&amp;publication_year=2024&amp;pages=4958-4972&amp;pmid=38952037&amp;doi=10.1111/bph.16479&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0084">
<span class="label">84.</span><cite>
Pope N. H., Salmon M., Davis J. P., et al., “D‐Series Resolvins Inhibit Murine Abdominal Aortic Aneurysm Formation and Increase M2 Macrophage Polarization,” FASEB Journal
30, no. 12 (2016): 4192–4201, 10.1096/fj.201600144RR.
</cite> [<a href="https://doi.org/10.1096/fj.201600144RR" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5102115/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27619672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20Journal&amp;title=D%E2%80%90Series%20Resolvins%20Inhibit%20Murine%20Abdominal%20Aortic%20Aneurysm%20Formation%20and%20Increase%20M2%20Macrophage%20Polarization&amp;author=N.%20H.%20Pope&amp;author=M.%20Salmon&amp;author=J.%20P.%20Davis&amp;volume=30&amp;issue=12&amp;publication_year=2016&amp;pages=4192-4201&amp;pmid=27619672&amp;doi=10.1096/fj.201600144RR&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0085">
<span class="label">85.</span><cite>
Spinosa M., Su G., Salmon M. D., et al., “Resolvin D1 Decreases Abdominal Aortic Aneurysm Formation by Inhibiting NETosis in a Mouse Model,” Journal of Vascular Surgery
68, no. 6S (2018): 93S–103S, 10.1016/j.jvs.2018.05.253.
</cite> [<a href="https://doi.org/10.1016/j.jvs.2018.05.253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6459013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30470363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Vascular%20Surgery&amp;title=Resolvin%20D1%20Decreases%20Abdominal%20Aortic%20Aneurysm%20Formation%20by%20Inhibiting%20NETosis%20in%20a%20Mouse%20Model&amp;author=M.%20Spinosa&amp;author=G.%20Su&amp;author=M.%20D.%20Salmon&amp;volume=68&amp;issue=6S&amp;publication_year=2018&amp;pages=93S-103S&amp;pmid=30470363&amp;doi=10.1016/j.jvs.2018.05.253&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0086">
<span class="label">86.</span><cite>
Elder C. T., Filiberto A. C., Su G., et al., “Maresin 1 Activates LGR6 Signaling to Inhibit Smooth Muscle Cell Activation and Attenuate Murine Abdominal Aortic Aneurysm Formation,” FASEB Journal
35, no. 8 (2021): e21780, 10.1096/fj.202100484R.
</cite> [<a href="https://doi.org/10.1096/fj.202100484R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9170188/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34320253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20Journal&amp;title=Maresin%201%20Activates%20LGR6%20Signaling%20to%20Inhibit%20Smooth%20Muscle%20Cell%20Activation%20and%20Attenuate%20Murine%20Abdominal%20Aortic%20Aneurysm%20Formation&amp;author=C.%20T.%20Elder&amp;author=A.%20C.%20Filiberto&amp;author=G.%20Su&amp;volume=35&amp;issue=8&amp;publication_year=2021&amp;pages=e21780&amp;pmid=34320253&amp;doi=10.1096/fj.202100484R&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0087">
<span class="label">87.</span><cite>
Filiberto A. C., Ladd Z., Leroy V., et al., “Resolution of Inflammation via RvD1/FPR2 Signaling Mitigates Nox2 Activation and Ferroptosis of Macrophages in Experimental Abdominal Aortic Aneurysms,” FASEB Journal
36, no. 11 (2022): e22579, 10.1096/fj.202201114R.
</cite> [<a href="https://doi.org/10.1096/fj.202201114R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11137679/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36183323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20Journal&amp;title=Resolution%20of%20Inflammation%20via%20RvD1/FPR2%20Signaling%20Mitigates%20Nox2%20Activation%20and%20Ferroptosis%20of%20Macrophages%20in%20Experimental%20Abdominal%20Aortic%20Aneurysms&amp;author=A.%20C.%20Filiberto&amp;author=Z.%20Ladd&amp;author=V.%20Leroy&amp;volume=36&amp;issue=11&amp;publication_year=2022&amp;pages=e22579&amp;pmid=36183323&amp;doi=10.1096/fj.202201114R&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0088">
<span class="label">88.</span><cite>
Bellotti P., Ladd Z., Leroy V., et al., “Resolvin D2/GPR18 Signaling Enhances Monocytic Myeloid‐Derived Suppressor Cell Function to Mitigate Abdominal Aortic Aneurysm Formation,” FASEB Journal
38, no. 18 (2024): e70067, 10.1096/fj.202400414RRR.
</cite> [<a href="https://doi.org/10.1096/fj.202400414RRR" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11433576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39320982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20Journal&amp;title=Resolvin%20D2/GPR18%20Signaling%20Enhances%20Monocytic%20Myeloid%E2%80%90Derived%20Suppressor%20Cell%20Function%20to%20Mitigate%20Abdominal%20Aortic%20Aneurysm%20Formation&amp;author=P.%20Bellotti&amp;author=Z.%20Ladd&amp;author=V.%20Leroy&amp;volume=38&amp;issue=18&amp;publication_year=2024&amp;pages=e70067&amp;pmid=39320982&amp;doi=10.1096/fj.202400414RRR&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0089">
<span class="label">89.</span><cite>
Awad K., Zaki M. M., Mohammed M., et al., “Effect of the Renin‐Angiotensin System Inhibitors on Inflammatory Markers: A Systematic Review and meta‐Analysis of Randomized Controlled Trials,” Mayo Clinic Proceedings
97 (2022): 1808–1823, 10.1016/j.mayocp.2022.06.036.
</cite> [<a href="https://doi.org/10.1016/j.mayocp.2022.06.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36202494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clinic%20Proceedings&amp;title=Effect%20of%20the%20Renin%E2%80%90Angiotensin%20System%20Inhibitors%20on%20Inflammatory%20Markers:%20A%20Systematic%20Review%20and%20meta%E2%80%90Analysis%20of%20Randomized%20Controlled%20Trials&amp;author=K.%20Awad&amp;author=M.%20M.%20Zaki&amp;author=M.%20Mohammed&amp;volume=97&amp;publication_year=2022&amp;pages=1808-1823&amp;pmid=36202494&amp;doi=10.1016/j.mayocp.2022.06.036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0090">
<span class="label">90.</span><cite>
Lieb W., Enserro D. M., Sullivan L. M., and Vasan R. S., “Residual Cardiovascular Risk in Individuals on Blood Pressure‐Lowering Treatment,” Journal of the American Heart Association
4, no. 11 (2015): e002155, 10.1161/JAHA.115.002155.
</cite> [<a href="https://doi.org/10.1161/JAHA.115.002155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4845218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26588944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Heart%20Association&amp;title=Residual%20Cardiovascular%20Risk%20in%20Individuals%20on%20Blood%20Pressure%E2%80%90Lowering%20Treatment&amp;author=W.%20Lieb&amp;author=D.%20M.%20Enserro&amp;author=L.%20M.%20Sullivan&amp;author=R.%20S.%20Vasan&amp;volume=4&amp;issue=11&amp;publication_year=2015&amp;pages=e002155&amp;pmid=26588944&amp;doi=10.1161/JAHA.115.002155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0091">
<span class="label">91.</span><cite>
Altun I., Oz F., Arkaya S. C., et al., “Effect of Statins on Endothelial Function in Patients With Acute Coronary Syndrome: A Prospective Study Using Adhesion Molecules and Flow‐Mediated Dilatation,” Journal of Clinical Medical Research
6, no. 5 (2014): 354–361, 10.14740/jocmr1863w.</cite> [<a href="https://doi.org/10.14740/jocmr1863w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4125330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25110539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Medical%20Research&amp;title=Effect%20of%20Statins%20on%20Endothelial%20Function%20in%20Patients%20With%20Acute%20Coronary%20Syndrome:%20A%20Prospective%20Study%20Using%20Adhesion%20Molecules%20and%20Flow%E2%80%90Mediated%20Dilatation&amp;author=I.%20Altun&amp;author=F.%20Oz&amp;author=S.%20C.%20Arkaya&amp;volume=6&amp;issue=5&amp;publication_year=2014&amp;pages=354-361&amp;pmid=25110539&amp;doi=10.14740/jocmr1863w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0092">
<span class="label">92.</span><cite>
Zaric B., Obradovic M., Trpkovic A., Banach M., Mikhailidis D. P., and Isenovic E. R., “Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications,” Current Medicinal Chemistry
27, no. 7 (2020): 1021–1040, 10.2174/0929867326666190903112146.
</cite> [<a href="https://doi.org/10.2174/0929867326666190903112146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31480995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Medicinal%20Chemistry&amp;title=Endothelial%20Dysfunction%20in%20Dyslipidaemia:%20Molecular%20Mechanisms%20and%20Clinical%20Implications&amp;author=B.%20Zaric&amp;author=M.%20Obradovic&amp;author=A.%20Trpkovic&amp;author=M.%20Banach&amp;author=D.%20P.%20Mikhailidis&amp;volume=27&amp;issue=7&amp;publication_year=2020&amp;pages=1021-1040&amp;pmid=31480995&amp;doi=10.2174/0929867326666190903112146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0093">
<span class="label">93.</span><cite>
Ridker P. M., Everett B. M., Thuren T., et al., “Anti‐ Inflammatory Therapy With Canakinumab for Atherosclerotic Disease,” New England Journal of Medicine
377 (2017): 1119–1131, 10.1056/NEJMoa1707914.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1707914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28845751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Anti%E2%80%90%20Inflammatory%20Therapy%20With%20Canakinumab%20for%20Atherosclerotic%20Disease&amp;author=P.%20M.%20Ridker&amp;author=B.%20M.%20Everett&amp;author=T.%20Thuren&amp;volume=377&amp;publication_year=2017&amp;pages=1119-1131&amp;pmid=28845751&amp;doi=10.1056/NEJMoa1707914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0094">
<span class="label">94.</span><cite>
Nidorf S. M., Fiolet A. T. L., Mosterd A., et al., “Colchicine in Patients With Chronic Coronary Disease,” New England Journal of Medicine
383, no. 19 (2020): 1838–1847, 10.1056/NEJMoa2021372.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2021372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32865380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Colchicine%20in%20Patients%20With%20Chronic%20Coronary%20Disease&amp;author=S.%20M.%20Nidorf&amp;author=A.%20T.%20L.%20Fiolet&amp;author=A.%20Mosterd&amp;volume=383&amp;issue=19&amp;publication_year=2020&amp;pages=1838-1847&amp;pmid=32865380&amp;doi=10.1056/NEJMoa2021372&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0095">
<span class="label">95.</span><cite>
Ridker P. M., Bhatt D. L., Pradhan A. D., et al., “Inflammation and Cholesterol as Predictors of Cardiovascular Events Among Patients Receiving Statin Therapy: A Collaborative Analysis of Three Randomised Trials,” Lancet
401, no. 10384 (2023): 1293–1301, 10.1016/S0140-6736(23)00215-5.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(23)00215-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36893777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Inflammation%20and%20Cholesterol%20as%20Predictors%20of%20Cardiovascular%20Events%20Among%20Patients%20Receiving%20Statin%20Therapy:%20A%20Collaborative%20Analysis%20of%20Three%20Randomised%20Trials&amp;author=P.%20M.%20Ridker&amp;author=D.%20L.%20Bhatt&amp;author=A.%20D.%20Pradhan&amp;volume=401&amp;issue=10384&amp;publication_year=2023&amp;pages=1293-1301&amp;pmid=36893777&amp;doi=10.1016/S0140-6736(23)00215-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0096">
<span class="label">96.</span><cite>
Yokoyama M., Origasa H., Matsuzaki M., et al., “Effects of Eicosapentaenoic Acid on Major Coronary Events in Hypercholesterolaemic Patients (JELIS): A Randomised Open‐Label, Blinded Endpoint Analysis [Published Correction Appears in Lancet. 2007 Jul 21;370(9583):220],” Lancet
369, no. 9567 (2007): 1090–1098, 10.1016/S0140-6736(07)60527-3.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(07)60527-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17398308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effects%20of%20Eicosapentaenoic%20Acid%20on%20Major%20Coronary%20Events%20in%20Hypercholesterolaemic%20Patients%20(JELIS):%20A%20Randomised%20Open%E2%80%90Label,%20Blinded%20Endpoint%20Analysis%20%5BPublished%20Correction%20Appears%20in%20Lancet.%202007%20Jul%2021;370(9583):220%5D&amp;author=M.%20Yokoyama&amp;author=H.%20Origasa&amp;author=M.%20Matsuzaki&amp;volume=369&amp;issue=9567&amp;publication_year=2007&amp;pages=1090-1098&amp;pmid=17398308&amp;doi=10.1016/S0140-6736(07)60527-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0097">
<span class="label">97.</span><cite>
Bhatt D. L., Steg P. G., Miller M., et al., “Cardiovascular Risk Reduction With Icosapent Ethyl for Hypertriglyceridemia,” New England Journal of Medicine
380, no. 1 (2019): 11–22, 10.1056/NEJMoa1812792.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1812792" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30415628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Cardiovascular%20Risk%20Reduction%20With%20Icosapent%20Ethyl%20for%20Hypertriglyceridemia&amp;author=D.%20L.%20Bhatt&amp;author=P.%20G.%20Steg&amp;author=M.%20Miller&amp;volume=380&amp;issue=1&amp;publication_year=2019&amp;pages=11-22&amp;pmid=30415628&amp;doi=10.1056/NEJMoa1812792&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0098">
<span class="label">98.</span><cite>
Budoff M. J., Bhatt D. L., Kinninger A., et al., “Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: Final Results of the EVAPORATE Trial,” European Heart Journal
41, no. 40 (2020): 3925–3932, 10.1093/eurheartj/ehaa652.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehaa652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7654934/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32860032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=Effect%20of%20Icosapent%20Ethyl%20on%20Progression%20of%20Coronary%20Atherosclerosis%20in%20Patients%20With%20Elevated%20Triglycerides%20on%20Statin%20Therapy:%20Final%20Results%20of%20the%20EVAPORATE%20Trial&amp;author=M.%20J.%20Budoff&amp;author=D.%20L.%20Bhatt&amp;author=A.%20Kinninger&amp;volume=41&amp;issue=40&amp;publication_year=2020&amp;pages=3925-3932&amp;pmid=32860032&amp;doi=10.1093/eurheartj/ehaa652&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bcpt70026-bib-0099">
<span class="label">99.</span><cite>
Chapman M. J., Zamorano J. L., and Parhofer K. G., “Reducing Residual Cardiovascular Risk in Europe: Therapeutic Implications of European Medicines Agency Approval of Icosapent Ethyl/Eicosapentaenoic Acid,” Pharmacology &amp; Therapeutics
237 (2022): 108172, 10.1016/j.pharmthera.2022.108172.
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2022.108172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35304222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20&amp;%20Therapeutics&amp;title=Reducing%20Residual%20Cardiovascular%20Risk%20in%20Europe:%20Therapeutic%20Implications%20of%20European%20Medicines%20Agency%20Approval%20of%20Icosapent%20Ethyl/Eicosapentaenoic%20Acid&amp;author=M.%20J.%20Chapman&amp;author=J.%20L.%20Zamorano&amp;author=K.%20G.%20Parhofer&amp;volume=237&amp;publication_year=2022&amp;pages=108172&amp;pmid=35304222&amp;doi=10.1016/j.pharmthera.2022.108172&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data sharing not applicable to this article as no datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Basic &amp; Clinical Pharmacology &amp; Toxicology are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/bcpt.70026"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/BCPT-136-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (337.5 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11955787/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11955787/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11955787%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11955787/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11955787/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11955787/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40159875/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11955787/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40159875/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11955787/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11955787/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="aVMZLPOCFg2UWU4dhLC0fzQwIZCTSjqMvQcYLKIunZD5mQhONN8OFJQRUh68FIMM">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
